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ABSTRACT 
Cartilage is a tissue that is critical for skeletal function, yet its study has been limited by a 
lack of quantitative, non-destructive, three-dimensional imaging techniques that enable 
simultaneous interrogation of both bone and cartilage. Recently, methods of contrast-
enhanced micro-computed tomography (CECT) have been developed that exploit the 
electrostatic interactions between ionic contrast agents and negatively charged 
glycosaminoglycans (GAGs) in cartilage, thus providing information about the 
composition and morphology of cartilage that was previously only available via 
destructive methods. The goal of this dissertation project was to apply CECT, a non-
destructive, three-dimensional imaging method, to understand the how the morphology 
and composition of cartilage changes in response to injury and disease.  First, CECT was 
applied to a model of growth plate injury to quantify changes to the cartilaginous tissue 
of the growth plate and formation of bone bridges within this tissue in response to injury. 
Using CECT, it was possible to identify increased thickness and CECT attenuation at the 
injury site. This result, paired with histological evidence of localized dysregulation of 
cellular activity, suggests that treatment designed to reduce bone bridge formation at the 
		 ix 
injury site should also consider the effects of the treatment on the adjacent cartilage. 
Second, CECT was applied to a collagen antibody-induced arthritis (CAIA) model to 
determine the role of the A2B adenosine receptor (A2BAR) in the arthritic deterioration of 
bone and cartilage. CECT scans demonstrated that loss of GAG in the cartilage preceded 
degeneration, but that ablation of the A2BAR in mice had little effect on the degenerative 
changes in bone and cartilage associated with CAIA. These results suggest that the 
A2BAR does not independently mediate these changes and that it may be necessary to 
target multiple adenosine receptors. Third, the ability of CECT to monitor the fracture 
healing and predict the stiffness of the cartilaginous fracture callus was assessed both at 
the level of the whole callus and at the level of the cartilage tissue. Callus stiffness was 
negatively correlated with the size of the callus and the amount of cartilage, while neither 
stiffness nor indentation modulus were correlated with CECT attenuation, suggesting that 
the stiffness of the cartilaginous fracture callus depends on the amount, rather than GAG 
content of cartilage. The work presented in this dissertation provides outlines changes in 
both bone and cartilage that occur in pathological conditions and provides new insights 
for both the treatment and assessment of these conditions. 
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CHAPTER ONE  
MOTIVATION 
Cartilage is integral to skeletal function, in development, growth, healing, and 
homeostasis. To better understand cartilage in these contexts, it is necessary for 
researchers to have tools for non-destructive assessment of this tissue While micro-
computed tomography (µCT) provides three-dimensional, non-destructive information 
about the microstructure, morphology, and composition of bone, this imaging modality 
has been unable to provide similar information about cartilage because of its low x-ray 
attenuation. Cartilage is instead traditionally characterized by histology, a method that is 
inherently two-dimensional and destructive, or by magnetic resonance imaging (MRI), a 
method that has inadequate resolution for studies of small animals and limited ability to 
characterize bone.  
Recently, a cationic contrast agent specific to cartilage whose attenuation is 
correlated to content of glycosaminoglycan (GAG), a molecule abundant in healthy 
cartilage, has been developed. Using contrast enhanced µCT (CECT), the morphology 
and composition of bone and cartilage can be characterized simultaneously. This method 
has the potential to provide information about cartilage composition and morphology that 
is otherwise not available using non-destructive methods. CECT can therefore be used to 
study a range of animal models of injury and disease. Thus far, CECT has been used to 
study fracture healing in mice, and to study deterioration of articular cartilage in 
osteoarthritis.  
In this project, I studied two additional injury and disease models involving 
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cartilage that were yet to be explored using CECT, growth plate injury and rheumatoid 
arthritis, and built upon previous work on fracture healing. Injury to the cartilaginous 
growth plate in children results in formation of bony bridges and disturbance of growth. 
Rheumatoid arthritis, an inflammatory autoimmune disease, results in destruction of 
cartilage and bone in the joints. CECT of the fracture callus can provide the composition 
information to fill this gap in knowledge. 
 The goal of this dissertation is to apply CECT to understand how the morphology 
and composition of cartilage responds to injury and disease. The project consists of three 
aims, each focused on an injury or disease model in mice. First, I quantified the local 
response of the growth plate cartilage to a pinhole injury, using CECT to detect changes 
in growth plate morphology, including formation of bony bridges. Second, I determined 
the role of the A2B adenosine receptor in rheumatoid arthritis by quantifying bone and 
cartilage degradation via µCT and CECT in a collagen antibody-induced model. Third, I 
assessed the ability of CECT to predict the compressive stiffness of the fracture callus 
and of the cartilage tissues in the callus. 
 This research addresses a range of clinically relevant questions related to cartilage 
using a three-dimensional, non-destructive method. Moreover, the CECT methods 
developed as part of this research can be applied to additional cartilage injury and disease 
models. 
  
		
3 
SPECIFIC AIMS 
AIM 1: Quantify the response of the growth plate cartilage to a pinhole injury using 
CECT detect spatially heterogeneous changes in growth plate morphology and 
composition. 
AIM 2: Determine the role of the A2B adenosine receptor in rheumatoid arthritis 
progression by quantifying bone and cartilage degradation via µCT and CECT in a 
collagen antibody-induced arthritis model. 
AIM 3: Estimate stiffness of the fracture callus and of the cartilage tissues in the callus 
by incorporating CECT data on the composition of the callus. 
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BACKGROUND 
Cartilage 
Cartilage plays key roles in various aspects of skeletal function, including development, 
and healing. Cartilage is a hydrated tissue, 70% water by weight. The solid matrix 
cartilage is made up of 30-70% collagen and 15-40% proteoglycan by weight (Figure 
1.1). Collagen is a triple-helical protein that forms cross-linked assemblies that provide 
cartilage’s tensile properties. The primary form of collagen in cartilage is type II 
collagen. Proteoglycans are composed of a central hyaluronic acid backbone to which 
glycosaminoglycan chains (GAG) are attached. GAGs are negatively charged on account 
of sulfate groups. The fixed negative charge density of the solid matrix of cartilage 
creates a swelling pressure that provides cartilage’s compressive stiffness. The cells of 
cartilage, chondrocytes, make up only 10% of the wet weight of cartilage. Since articular 
cartilage is not a vascularized tissue, chondrocytes must depend upon diffusion for 
delivery of nutrients and oxygen. 
Figure 1.1 Schematic of the structure of cartilage, composed of collagen fibrils and 
proteoglycans. (1) 
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Contrast Enhanced Computed Tomography 
Despite cartilage’s key role in skeletal function, characterization methods 
commonly used in research and clinical assessment have limitations with respect to 
quantifying changes in cartilage that occur as a result of injury and disease. Histology is 
currently the gold standard for characterization of cartilage, yet this method is inherently 
two-dimensional, providing limited information about morphology, and destructive, 
preventing further characterization of the sample. Magnetic resonance imaging (MRI) 
and micro-computed tomography (µCT) are both three-dimensional and non-destructive 
methods; however, each has limitations with respect to characterization of cartilage. Use 
of delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in conjunction with MRI 
allows visualization of cartilage in humans, (2) yet the resolution of MRI is not high 
enough for studies using small animals. Moreover, while MRI can provide limited 
information about bone microstructure, it cannot provide quantitative information about 
bone density. While µCT is capable of achieving the high resolution necessary for 
quantification of bone in small animals such as mice, soft tissues with high water content, 
such as cartilage, have low density compared to mineralized tissues and therefore exhibit 
low x-ray attenuation.  
 To overcome the challenge of the low x-ray attenuation of cartilaginous tissues, 
contrast agents have been developed based on the presence of negatively charged 
glycosaminoglycans (GAGs) in cartilage (Figure 1.2). Commercially available anionic 
contrast agents are excluded from regions with high GAG content and provide an inverse 
relation between attenuation and GAG content. (3-5) Conversely, an iodinated cationic 
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contrast agent, CA4+, has been developed to be electrostatically attracted to the GAGs in 
cartilage (Figure 1.3). (6) Attenuation of CA4+ is correlated with GAG content and 
corresponds to spatial variations in GAG content in articular cartilage and meniscus. (7-
9) Furthermore, this correlation between attenuation and GAG content is stronger for 
CA4+ than for anionic contrast agents. (10) Attenuation of CA4+ is also correlated with 
equilibrium compressive modulus and coefficient of friction in bovine, murine, and 
human articular cartilage. (7, 11-13) The ability of CA4+ agents to provide information 
about the composition and mechanical properties, both of which may be altered in 
pathological states, makes contrast enhanced µCT (CECT) a promising tool for 
characterizing the response of cartilaginous tissues to injury and disease. 
 
  
Figure 1.2 Schematic demonstrating the interactions of ionic contrast agents with 
negatively charged GAGs (blue) in cartilage. Left, anionic contrast agents (red) are 
excluded from regions containing GAGs. Right, cationic contrast agents (green) are 
attracted to GAGs.(14) 
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Figure 1.3 Chemical structure of the iodinated cationic contrast agent, CA4+. (6) 
 
Growth Plate 
Growth Plate Physiology 
The growth plate, or physis, is the cartilaginous tissue at the end of long bones and is the 
primary structure responsible for longitudinal growth of bones. This tissue is separated 
into three zones based on cellular activity (Figure 1.4). In the reserve zone, cells are 
relatively inactive. In the proliferative zone, cells actively divide. In the hypertrophic 
zone, cells stop dividing and grow larger as mineralization begins. In adult humans, the 
growth plate is completely mineralized and growth ceases. 
In addition to having different cellular activities, the zones of the growth plate 
have different GAG contents. Initial study of the growth plate zones indicated that the 
GAG content was similar in the resting and proliferative zones, increased in the 
hypertrophic zone, and decreased abruptly as the growth plate mineralizes. (15) In 
addition, proteoglycan aggregate size decreased in the proliferative and hypertrophic 
zones. (16) These observations led many investigators to theorize that proteoglycans must 
be removed in order for mineralization to occur. However, more recent work indicates 
that changes in the chemical composition of the GAGs may drive the mineralization of 
the growth plate. For example, the concentration of over-sulfated GAGs is higher in the 
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hypertrophic zone than in the proliferative zone. (17) At the same time, the size of 
monomers and the size of sulfate chains  increases going from the proliferative zone to 
the hypertrophic zone. (18) These changes in sulfation may play a role in mineralization. 
It is possible that zonal differences in GAG content and changes in GAG content over the 
course of mineralization could be detected using CECT. 
Figure 1.4 Micrograph of a 2 µm thick section of a rat proximal tibial growth plate 
showing the cellular zones of growth plate cartilage: reserve zone, proliferative zone, 
hypertrophic zone, and calcification zone.(19) 
Growth Plate Injury 
Injury to the growth plate before skeletal maturity is of great clinical significance. The 
cartilaginous growth plate in children is 2-5 times weaker than surrounding bone, making 
it vulnerable to injury. In fact, up to 30% of sports injuries in children involve the growth 
plate. (20) Growth plate injuries often result in growth disturbances, leading to 
malformities and discrepancies in limb length of up to 2 cm. (20, 21) Clinical imaging of 
growth plate injuries indicate that these growth disturbances are caused by formation of 
bony bridges across the growth plate. (22, 23) Salter and Harris categorized growth plate 
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injuries based on which portions of the bone they involve (Figure 1.5). (24) Growth plate 
injuries that span the epiphysis and metaphysis (Type IV) cause the greatest growth 
disturbances and discrepancies in limb length. (21)  
 
Figure 1.5 Salter-Harris classification of growth plate injury. I Fracture involving physis, 
II Fracture involving physis and metaphysis, III Fracture involving physis and epiphysis, 
IV fracture involving metaphysis and epiphysis, V Compression of the physis. (25) 
 
 A model of a defect in the growth plate of rats, representing a type IV injury, has 
been used to investigate what factors contribute to bony bridge formation and premature 
growth arrest. (26) Following growth plate injury in rats, there is a progression similar to 
traditional fracture healing, including an inflammatory response (1-3 days), a fibrogenic 
response (3-10 days), and an osteogenic response characterized by formation of bony 
bridges (7-25 days), followed by bony bridge maturation and remodeling. (26) While the 
volume of bone within the defect region does not increase beyond day 28, the volume of 
bony bridges outside the defect region continues to increase through day 56. (25) As 
much as 16% of the growth plate may be replaced by bone by day 60. (27) Although 
formation of bony bridges is common as in rats as they age, the volume fraction of bony 
bridges is greater in injured rats than in age-matched, uninjured controls. (25, 27) 
Furthermore, in rats injury to the growth plate causes a more rapid decrease in thickness 
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over time compared to the decrease in thickness normally seen with aging. (25) Both the 
percent change in volume fraction of bony bridges and percent change in thickness are 
correlated to the amount of reduction of limb length in injured rats compared to age-
matched, uninjured controls. (25)  
 While it is clear that bony formation of bony bridges contributes to growth 
disturbances, it is unclear how bony bridges form. Bone can form either with a cartilage 
template (endochondral ossification) or directly without a cartilage template 
(intramembranous ossification). Initially, lack of evidence of chondrocyte differentiation, 
paired with evidence of osteoblast differentiation, suggested that bony bridges form via 
intramembranous ossification, rather than endochondral ossification. (26, 28) However, 
more recently, expression of cartilage-specific collagen genes at the defect site during the 
fibrogenic response stage indicates that bony bridge formation is a combination of 
intramembranous and endochondral ossification. (29, 30) While studies have primarily 
focused on factors that contribute to formation of bone bridges at the injury site, 
researchers have also noted effects in the reserve, proliferative, and hypertrophic zones in 
the growth plate cartilage adjacent to the injury site. (25-27, 31, 32)  Indeed, many growth 
factors and cytokines identified during growth plate injury are also regulators of 
chondrocyte proliferation and hypertrophy in growth plate cartilage, including vascular 
endothelial growth factor, inflammatory factors cycloxyenase-2 and interleukin-1b, 
growth factors fibroblast growth factor and insulin-like growth factor, and bone 
morphogenetic proteins. (28, 33-41) Use of CECT would make it possible to monitor 
spatial changes in the cartilage near the injury site, while also monitoring formation of 
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bony bridges. This method may shed additional light on the mechanism by which bony 
bridges form. 
 
Rheumatoid Arthritis 
Clinical Significance of Rheumatoid Arthritis 
Rheumatoid arthritis (RA) is an inflammatory, autoimmune disease that leads to 
destruction of articular cartilage and subchondral bone at joints (Figure 1.6). RA is less 
common than other bone disorders, but it leads to severely decreased quality of life. RA 
affects between 0.5% and 1.0% of the population and affects women more often than 
men. (42, 43) Although RA is rarely the cause of death, RA patients have increased 
mortality compared to healthy controls. (43, 44) RA patients are often at risk for other 
conditions, including fracture of the hip or vertebra. (45-47) In addition, pain associated 
with RA is a common reason for work disability: 35% of RA patients are unable to work 
within 10 years of disease onset. (48) Work disability contributes greatly to the monetary 
cost of RA to society. Indirect costs, such as disability, constitute 52% of the costs of RA, 
while direct costs, such as medical care, constitute only 48% of the costs of RA. (49) 
These factors motivate researchers to understand the progression of RA and identify 
molecular targets for drug therapy.  
Since RA is an inflammatory, autoimmune disease, cytokines, signaling 
molecules that mediate immune responses, play an important role. Two common 
cytokines, tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6), have elevated levels 
in synovial fluid and serum of RA patients. (50, 51) TNF-α is believed be a key mediator 
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of the immune response, capable of activating downstream pathways. In addition to their 
role in the immune response, both TNF-α and IL-6 contribute to the differentiation of 
osteoclasts, the cells that resorb bone tissue. (52-54) In healthy bone, the activity of 
osteoclasts is balanced by osteoclasts, the cells that form new bone. The role of cytokines 
in both inflammation and bone destruction in RA suggests that they are key in 
understanding the progression of RA and identifying molecular targets for therapy. In 
particular, it the receptors that activate these cytokines would be potential targets for 
therapy. 
Figure 1.6 Schematic showing A) a healthy synovial joint and B) a synovial joint of a 
patient with rheumatoid arthritis. (55) 
Animal Models of Rheumatoid Arthritis 
Over the past 40 years, researchers have worked to develop appropriate animal models 
for RA. Although each of these models can recapitulate the clinical signs of RA. Initial 
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models, called adjuvant arthritis, induced an arthritic response by injecting fragments of 
bacteria. However, early studies demonstrated that type II collagen antibody 
concentrations were increased in the sera of rheumatoid arthritis patients, suggesting that 
the autoimmune response in rheumatoid arthritis may be driven by type II collagen. (56) 
A collagen-induced arthritis (CIA) model was first developed in rats (57) and 
later applied to mice. (58) In both of these models, animals injected with type II collagen 
show a response similar to RA, including swollen paws and histological evidence of 
pannus development and subsequent bone and cartilage erosion.  Translation of the CIA 
model to mice allows the potential for using knock-out models that allow the role of 
particular genes to be determined; however, certain strains are more susceptible to CIA 
than others. (59) Although rheumatoid arthritis in humans is a chronic disease, CIA tends 
to be a more acute disease. 
 The presence of type II collagen antibodies in the sera of rheumatoid arthritis 
indicated that the antibodies themselves may be able to induce arthritis. Collagen 
antibody-induced arthritis (CAIA) models typically use a cocktail of three to four type II 
collagen monoclonal antibodies (mAb) and demonstrate both clinical and histological 
evidence of arthritis similar to that observed in CIA and RA. (60, 61) Although it is 
possible to induce arthritis with a single mAb, (62) the duration of the disease is higher 
(61) and the necessary dose is lower (63) when the cocktail is used. Similar to CIA, 
certain strains of mice are more susceptible to CAIA.(61) For example, BALB/c mice are 
most susceptible, while C57BL/6 are the least susceptible. However, strains that are CIA-
resistant are susceptible to CAIA, making CAIA more broadly applicable than CAI. 
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Similar to CIA, CAIA is an acute, rather than chronic, disease; however, CAIA has a 
more rapid onset than CIA. (61) Both the broader applicability and rapid onset make 
CAIA a more useful model for arthritis in mice, particularly when using transgenic mice. 
A2B Adenosine Receptor 
Adenosine is a small molecule that mediates many physiological processes, including 
inflammation. Adenosine mediates inflammation through four G-protein coupled 
adenosine receptors: A1, A2A, A2B, and A3. A1 and A3 inhibit adenylate cyclase and 
decrease production of cAMP, while A2A and A2B stimulate andenylate cyclase and 
increase production of cAMP. The A2 receptors are distinguished by the high and low 
affinities of A2A and A2B, respectively, for adenosine; thus A2B tends to be activated only 
at high, pathological adenosine levels. (64)  
Adenosine receptors are expressed in the synovial tissues of RA patients (65) and 
in human osteoprogenitor cells and human bone marrow stromal cells in culture, (66) 
indicating that adenosine receptors play a role in the inflammatory processes in RA that 
lead to bone destruction.  Treating human osteoprogenitor cells with general agonists to 
adenosine receptors increases cAMP levels, and treatment with agonists to specific 
adenosine receptors indicates that the A2B adenosine receptor is dominant in these cells. 
Adenosine receptors mediate the production and release of key proinflammatory 
cytokines involved in the inflammatory processes in RA. These processes are studied 
using both pharmacological methods, using agonists (to activate the receptors) and 
antagonists (to deactivate the receptors), and transgenic methods, (to knock out each 
adenosine receptor). For example, treatment of cultured cells with N-
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ethylcarboxamidoadenosine (NECA), a general adenosine receptor agonist, stimulates IL-
6 release. (66, 67) In these studies, use of an A2B adenosine receptor agonist (Alloxazine) 
(66) or an A2B adenosine gene knockout system confirmed the A2B adenosine receptor’s 
role in IL-6 modulation. (67)   
Studies indicate that the A2 adenosine receptors inhibit release of TNF-α, yet there 
is some debate over whether the A2A or A2B receptor dominates this response. (68) A2A 
adenosine receptor knockout mice had increased TNF-α levels following LPS treatment, 
compared to wild type mice, indicating that the A2B adenosine receptor inhibits TNF-α 
release. (69) However, another study showed that NECA was still able to inhibit TNF-α 
release in both A2B knockout and wild type mice, indicating that A2B does not play an 
important role in TNF-α inhibition. (67) In another study, treatment with a new A2B 
adenosine receptor-specific agonist (BAY 60-6583) inhibited TNF-α expression in wild 
type, but not A2B knockout mice, indicating that A2B does play an important role in TNF-
α inhibition. (70) Since these cytokines mediate the inflammatory responses in RA, 
studying the A2B adenosine receptor in a knock out system could lead to identification of 
targets for therapy. 
 In addition to mediating inflammatory processes, adenosine receptors mediate the 
production of matrix metalloproteinases (MMPs), which contribute to degradation of the 
articular cartilage matrix. Adenosine deaminase (ADA) is an enzyme that catalyzes the 
irreversible conversion of adenosine to inosine, reducing adenosine levels. RA patients 
have increased ADA activity, and this increased ADA activity is correlated with 
increased MMP-9 concentration. (71) Furthermore, exposing cartilage explants to ADA 
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increases GAG production and increases MMP-13 and MMP-3 production. (72) 
Adenosine is thought to mediate MMP production through the A2B adenosine receptor 
specifically. In fibroblast-like synoviocytes stimulated by IL-1, general agonist NECA 
reduces IL-1-induced production of MMP-1 and MMP-3, but agonists specific to A1, 
A2A, and A3 do not. (73) This study was performed before identification of an A2B-
specific agonist and therefore demonstrates indirectly that reduction of MMP production 
is mediated by the A2B adenosine receptor. Once the A2B-specific agonist, BAY 60-6583, 
was developed, it was possible to demonstrate directly that the A2B adenosine receptor 
mediates reduction of MMP-9 production in a model of vascular injury. (74) These 
studies demonstrate that the A2B adenosine receptor could play a key role in degradation 
of the cartilage matrix in RA, a process that can be monitored using CECT. 
 Adenosine and adenosine receptors also play a role in differentiation of bone cells 
and formation of bone. The A2B adenosine receptor in particular is highly expressed in 
human osteoprogenitor cells and differentiating osteoblasts. (66, 75-77)Indeed, alkaline 
phosphatase activity and expression of osteoblast differentiation markers, including 
Runx2, collagen type I, and osteocalcin increase in osteoprogenitor cells treated with 
adenosine receptor agonist NECA, indicating osteogenic differentiation. (75-79) 
Addition of adenosine increases mineralization in culture, but this increase is reversed by 
an A2B adenosine receptor antagonist (MRS1706). (76) Similarly, in A2B  cells from 
adenosine receptor knockout (“A2BAR KO”) mice, expression of osteoblast 
differentiation markers, Runx2 and Osterix, was reduced. Treatment of wild-type cells, 
but not A2BAR KO cells, with NECA increases expression of these osteoblast 
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differentiation markers, confirming that the A2B adenosine receptor is responsible for this 
change. (79) With a role in both osteoblastogenesis and osteoclastogenesis, the role of 
A2BAR in bone turnover is complex. On the other hand, treatment with an A2B adenosine 
receptor agonist inhibited production of osteoprotegerin (OPG), an inhibitor of 
osteoclatogenesis, leading to overall reduced OPG/RANKL ratios. (66, 80) These A2BAR 
KO mice also have altered bone morphology, including shorter femora, thinner cortices, 
and lower tissue mineral density. These studies demonstrate the A2B adenosine receptor 
could play a key role in bone formation and destruction in RA, a process that can be 
monitored using CECT. 
 Another way in which that the A2B adenosine receptor may contribute to 
progression of rheumatoid arthritis is via vascularization of the pannus. In a study of 
polymorphonuclear neutrophils, treatment with TNF-a induced release of vascular 
endothelial growth factor (VEGF), a stimulator of angiogenesis, while treatment with 
adenosine inhibited VEGF release. (81) Application of adenosine agonists and 
antagonists indicated that adenosine inhibits angiogenesis through the A2B adenosine 
receptor. In contrast, treatment of endothelial cells with adenosine agonists and 
antagonists indicated instead that the A2B adenosine receptor stimulates VEGF release. 
(82) Moreover, treatment of endothelial cells with adenosine and NECA enhanced 
formation of endothelial cell tubes, indicating enhanced angiogenesis potential. (83) 
Further study indicated that this enhanced angiogenesis was stimulated by VEGF and 
endothelial nitric oxide synthase via the A2B adenosine receptor. Vascularization of the 
pannus may, therefore, be impacted by the A2B adenosine receptor and lead to 
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downstream effects on bone and cartilage degradation. 
 Thus far, study of adenosine receptors in animal models of arthritis has been 
limited to adjuvant arthritis in rats.  Rats treated with the A1, A2A, and A3 adenosine 
receptor agonists showed clinical evidence of reduced swelling, radiographic evidence of 
bone reduced destruction, and histological evidence of reduced cartilage destruction. (84-
86) The A2B adenosine receptor has not yet been studied in an animal model of RA, and 
adenosine receptors in general have not yet been studied in a CAIA model of RA. The 
A2B adenosine receptor is likely to be highly relevant in a CAIA model of RA, because of 
its effect on levels of cytokines, MMPs, and osteoblast differentiation markers. 
Imaging of Rheumatoid Arthritis 
Imaging of RA has focused primarily on identification of erosions, localized breaks in the 
cortical shell. Clinically, radiography is the gold standard for detecting erosions, yet this 
method is unable to detect erosions in the early stages of the disease. (87) Both 
ultrasound (US) and MRI are more sensitive than radiography in detecting erosions. (88) 
However, µCT is even more sensitive than US and MRI and can detect even smaller 
erosions, while providing additional information about bone microstructure. (89) Despite 
differences in sensitivity, the volume of erosions measured by MRI and µCT are well 
correlated, (90) and the changes detected with both methods are consistent with 
histological findings. (91) One advantage of MRI is that it can provide additional 
information about soft tissue, including the synovium and articular cartilage. dGEMRIC 
has been used to demonstrate that while GAG content of the articular cartilage is 
decreased in RA patients, the thickness of articular cartilage is unchanged. (92-94) 
		
19 
However, MRI cannot provide detect changes in bone microstructure, and MRI does not 
have the necessary resolution for small animal models of RA. For this reason, applying 
CECT to an animal model of RA will provide previously unavailable information about 
degradation of both bone and cartilage in RA. 
 
Fracture Healing 
Biological and Mechanical Stages of Fracture Healing 
Bone has the capacity to repair itself completely following injury. Once the fracture 
healing process is complete, the fracture gap is replaced with normal bone tissue, rather 
than the scar tissues that result from injury to other organs and tissues. Normal fracture 
healing of long bones has four biological phases: inflammation, formation of a 
cartilaginous callus, replacement of the cartilaginous callus with a bony callus, and 
remodeling of the bony callus to restore the bone’s original shape and microstructure. 
(95) The cartilaginous callus both stabilizes the fractured bone and provides a template 
for endochondral ossification. In mice with closed, stabilized fractures, the cartilaginous 
callus begins forming by day 7, the bony callus begins forming by day 14, and the callus 
is remodeled by day 28. (96)  
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Figure 1.7 Biological Stages of fracture healing. (97) 
In addition to these biological phases, fracture healing is also characterized by 
mechanical phases. (98) In the first phase, failure in torsion occurs at the fracture site 
with low stiffness, representing failure of soft tissue, the cartilaginous callus. In the 
second phase, failure occurs at the fracture site with high stiffness, representing hard 
tissue behavior. In the third phase, failure occurs both at the fracture site and intact bone 
with high stiffness. Finally, in the fourth phase, failure occurs completely in intact bone 
with high stiffness, representing a restoration of the original strength. This restoration of 
strength is often considered and endpoint for fracture healing. 
Impaired Fracture Healing 
When the normal fracture healing process is impaired, delayed union or non-
union can occur. Twenty percent of patients experience non-union; these patients require 
additional surgery, and the cost of their care is more than twice that of patients with 
fractures that heal normally. (99) Since normal fracture healing depends of stabilization 
of the bone, incidence of delayed union and non-union depend of the fracture fixation 
methods. (100) In addition to mechanical factors, many biological and molecular factors 
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determine whether fracture healing is impaired. For example, fracture healing is impaired 
in mice deficient in TNF-α, (101) MMP-9, (102) or MMP-2. (103) 
Figure 1.8 Torque-angular displacement graph of fractured rabbit tibiae at time points 
representative of the four biomechanical phases of healing. The numbers associated with 
each curve indicate days post fracture. Days 21, 24 and 26 represent Phase I, Day 27 
represents Phase II, Day 49 represents Phase III, and Day 56 represents Phase IV. (98) 
Assessment of Fracture Healing 
It is important for doctors to have accurate and objective methods to assess fracture 
healing. First, these methods allow doctors to determine whether fracture healing is 
impaired and to prescribe additional treatment. Second, these methods allow doctors to 
identify an endpoint for fracture healing and to advise patients to return to a normal 
activity level. Since the ability of the fractured bone to bear weight is critical for a 
positive outcome, assessments of fracture healing are typically based on restoration of 
mechanical properties (i.e. entering the fourth mechanical phase of healing). If a fracture 
is stabilized using an external fixation device, it is possible to monitor callus stiffness and 
use that information to determine an endpoint for fracture healing. (104-107) However, 
		
22 
this method cannot be applied to fractures stabilized with plaster casts or intramedullary 
rods. 
 For a more broadly applicable method of assessing fracture healing, non-invasive, 
clinical imaging methods must instead be correlated to mechanical properties of the 
callus. Radiographs are considered a gold standard for assessing fracture healing, yet 
there is interobserver variability in the interpretation of radiographs by orthopaedic 
surgeons. (108) For this reason, surgeons developed the Radiographic Union of Tibial 
Fractures (RUST) system based on cortical bridging of the fracture gap to reduce 
interobserver variability. (109) To further reduce interobserver variability, there has been 
effort to develop automatic methods to measure callus area and identify cortical bridging,  
yet these methods are still limited to two-dimensional assessment of bone during fracture 
healing. (110)  
CT, in contrast, provides three-dimensional information about callus composition 
and morphology that is correlated to mechanical properties. CT may be a particularly 
useful tool for identifying an end point, since µCT parameters of the healing callus, 
including tissue mineral density (TMD), callus volume, and polar moment of inertia, 
approach those of the contralateral over time. (111)  The TMD of the callus is correlated 
with bending stiffness,(112) compressive strength, (113) and torsional strength and 
stiffness. (114-116) The cross-sectional moment of inertia (CSMI) is positively correlated 
to both failure load and stiffness in bending. (117) Based on regression analysis, Morgan 
et al. found that TMD, bone volume (BV), and standard deviation of mineral density 
(σTMD) explain 62% of variation in torsional strength, while TMD, bone mineral content 
		
23 
(BMC), bone volume fraction (BV/TV), σTMD and explain 70% of variation in torsional 
stiffness. (114) Furthermore, the moment of inertia is a significant, but less strong, 
predictor of torsional stiffness. Nazarian et al. paired structural rigidity analysis with µCT 
analysis to predict torsional stiffness. (115) This study is in agreement with Morgan et al. 
with regards to TMD and TMC. However, Nazarian et al. found that moment of inertia 
was correlated to torsional strength, rather than torsional stiffness. In contrast to TMD 
and moment of inertia, callus volume has a negative correlation to bending stiffness (118) 
and no correlation to torsional strength or stiffness. (116) Similarly, callus area has a 
weak negative correlation to bending stiffness. (112) Callus volume is negatively 
correlated to callus TMD, suggesting that large calluses have inferior mechanical 
properties because they are less mineralized. (116) Thus, while µCT measurements of 
callus volume and area do not predict callus mechanical properties, TMD and, 
potentially, area moments of inertia can be used to predict callus mechanical properties. 
For more accurate µCT-based estimates of callus stiffness, voxel-based finite element 
model have been used.  In a model where each voxel in the callus a tissue type (highly 
mineralized bone, newly mineralized bone, or soft tissue) with a corresponding elastic 
modulus, the predicted torsional stiffness of rat fracture calluses is correlated to the 
experimental torsional stiffness. (119) 
Contrast-Enhanced µCT of the Fracture Callus 
CECT has been used in animal models of fracture healing to identify cartilage in the 
fracture callus. CECT using CA4+ enables three-dimensional visualization of cartilage in 
the fracture callus and reveals differences in callus morphology between strains of mice 
		
24 
known to have different fracture healing patterns. (120) The area labeled by CA4+ in 
CECT scans is correlated with the area labeled by safranin O in histological sections, 
indicating that CECT accurately identifies cartilage in the fracture callus. (120, 121) 
Furthermore, CECT can identify mineralized cartilage in the fracture callus. (121) Spatial 
variations in CT attenuation correspond to variations in safranin O staining intensity, 
indicating that variation in GAG content may captured by CECT. (120) However, no 
quantitative assessment of GAG content has been performed yet.  
 
 
Figure 1.9 CECT of the fracture callus A) Histological section of mouse fracture callus. 
Safranin-O stains cartilage red. B) CECT slice of mouse fracture callus. Blue=un-
mineralized cartilage, red=mineralized cartilage. C) 3D rendering of bone (red), cartilage 
(blue), and non-cartilaginous soft callus (yellow) identified by CECT. (121) 
 
While CECT has been validated as a tool for identification of cartilage in the 
fracture callus, this method has not been correlated to mechanical properties. CECT, 
paired with nanoindentation, would reveal information about the spatial variations of 
GAG content and mechanical properties in the cartilage of the fracture callus and would 
provide more accurate input for finite element models. 
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CHAPTER TWO : LOCAL CHANGES TO THE DISTAL FEMORAL GROWTH 
PLATE FOLLOWING INJURY 
 INTRODUCTION 
The growth plate, or physis, is the cartilaginous tissue responsible for longitudinal 
growth of bones. Damage to the growth plate occurs in up to 30% of sports injuries in 
children and increases risk of growth disturbance. (20, 122) This growth disturbance may 
take the form of premature fusion of the growth plate and growth arrest, leading to 
potential discrepancies in limb length and angular deformities. (21, 123) Radiographic 
evidence indicates that growth disturbances are associated with formation of bone bridges 
at the injury site. (124) Moreover, angular deformities occur when growth is inhibited in 
some, but not all, regions of the growth plate. (123) While growth disturbance can be 
minimized with appropriate surgical intervention, these interventions are only successful 
in patients when the bone bridges affect less than 50% of the growth plate and when the 
location of the bone bridges is known precisely. (122) Animal models have similarly 
indicated that whether growth disturbance occurs depends on the size of the injury. (125) 
Thus, to develop effective treatments, it is imperative to understand how injury to the 
growth plate results in deleterious changes to development of cartilaginous tissue and 
formation of bone bridges. 
 Thus far, researchers have used animal models in studies primarily focused on 
changes directly at the injury site and on the cellular and molecular processes that 
regulate formation of bone bridges. The injury response consists of four phases: 
inflammatory, fibrogenic, osteogenic, and remodeling. (26) Throughout the formation of 
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bone bridges, bone-related genes (runx2 and osteocalcin) and cartilage-related genes 
(collagen X, collagen II, and sox9) are upregulated at the injury site, indicating both 
endochondral ossification (formation of bone indirectly, via a cartilaginous template) and 
intramembranous ossification (direct bone formation). (26, 29, 30, 126) The amount of 
bone at the injury site increases over time, and during the later phases of the injury 
response, bone bridges form outside the injury site. However, conflicting reports exist on 
the presence of bone bridges in control (contralateral or age-matched) growth plates. (25, 
27) Prior studies also reported conflicting results for growth plate thickness, with one 
study finding a reduction in thickness in injured vs. contralateral growth plates, (25) and 
another finding no difference in thickness between injured and control growth plates. (27) 
Histological evidence suggests that growth plate thickness increases immediately 
adjacent to the injury. (127) This observation indicates the effect of injury on physeal 
thickness may vary locally in ways not captured robustly by average measurements, thus 
resolving discrepancies of the effect of injury on growth plate thickness seen in previous 
studies. Indeed, adjacent to the injury site, researchers have noted effects in the different 
zones of the growth plate: reserve, proliferative, and hypertrophic. (25-27, 31, 32) A 
central, unanswered question is how local changes in composition and cellular activity in 
the growth plate contribute to disturbance of growth and formation of bone bridges 
within and outside the injury site.  
  The goal of this study was to quantify spatial changes in morphology and 
composition of the growth plate that occur following injury. We used contrast-enhanced 
micro-computed tomography (CECT), a non-destructive method that enables 
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quantitative, three-dimensional examination of cartilaginous and osseous tissues, (6) to 
simultaneously quantify local changes in growth plate thickness, bone formation, and 
CECT attenuation (a parameter that is correlated with glycosaminoglycan (GAG) content 
(7, 10)). We also investigated local changes in cellular activity in response to injury using 
histology. 
 
METHODS 
Animal model 
All animal experiments were conducted under a protocol approved by the Institutional 
Animal Care and Use Committee (IACUC) at the Boston University School of Medicine 
(Boston, MA). A pinhole defect was created in the distal femoral growth plate of 48 four-
week-old, male, C57BL/6J mice (Jackson Labs, 16.4±2.0g at time of procedure). The 
surgical method was adapted from a method for inserting an intramedullary pin prior to 
induction of a closed femoral fracture. (128) An incision was made medial to the patella 
to displace the patellar tendon and expose the femoral condyles.  A 0.51mm-diameter pin 
(4.7± 0.1% of growth plate area 7 days following surgery) was inserted between the 
condyles in a retrograde fashion to create the defect, and the incision was closed with 
grade-5 sutures. Mice were randomly assigned to groups that were euthanized via carbon 
dioxide asphyxiation at 7, 21, or 42 days following injury. Injured and contralateral 
femora were harvested, measured with calipers from the tip of the greater trochanter to 
the lateral condyle, and frozen at -80°C in saline-soaked gauze. The length of a subset of 
femora (n=25) was also measured from plain-film radiographs that were subsequently 
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digitized (ImageJ, National Institutes of Health, Bethesda, MA). (129) The lengths 
measured via calipers and from the digital images were highly correlated (p<0.0001, 
R2=0.71). Five mice were excluded from analysis because the growth plate was damaged 
during harvest, and five mice were excluded because the defect did not penetrate the 
growth plate, resulting in group sizes of 12, 13, and 13 for the day-7, 21, and 42 groups, 
respectively.   
CECT scanning 
A 3-mm length of the distal femur, which included the growth plate, was scanned in air 
using a desktop micro-computed tomography (µCT) system (µCT40, Scanco Medical, 
Brüttisellen Switzerland; 6µm/voxel, 70kV, 114mA, and 200ms integration time). Scans 
were performed before (pre-incubation) and after (post-incubation) incubation in 27mg 
iodine/mL solution of CA4+ (pH 7.4, 350-450mOsm), penicillin-streptomycin, and 
protease inhibitor for 14 hours. (6, 120) 
Histology  
Following µCT scanning, femora were incubated in PBS for 24 hours to clear contrast 
agent. Femora were fixed in paraformaldehyde, decalcified in EDTA, dehydrated in 
ethanol, embedded in paraffin, and sectioned into 7-µm-thick sagittal slices. Sections 
were stained with hematoxylin, Fast Green, and safranin-O to visualize cell morphology 
and tissue types. 
CECT image processing and analysis of cartilage 
The growth plate cartilage was segmented using a previously published protocol. (120, 
121) Stacks of images from the pre- and post-incubation µCT scans were aligned using 
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an affine registration constrained to rigid body transformation (Amira 5.2.2, Visage 
Imaging, Andover, MA). The pre-incubation image was subtracted from the post-
incubation image, and cartilage was identified by applying a threshold on the subtracted 
image. This threshold was based on a four-part Gaussian fit of the intensity histogram of 
the subtracted image. (121)  The threshold was determined such that more than 50% of 
all voxels with intensities above the threshold are expected to be cartilage. Contiguous 
voxels above this threshold located within the growth plate region were manually 
selected, eliminating any non-contiguous voxels which generally represented noise, 
registration error or articular cartilage. Thickness of the growth plate was calculated 
using distance-transformation methods (Scanco Medical). CECT attenuation was 
measured as an estimate of GAG content. (7, 10) The average thickness and CECT 
attenuation of the growth plate were measured within a 1mm-diameter volume of interest 
(VOI) centered at the injury site (“near”; Figure 2.2D inset) and also within the rest of the 
growth plate (“far”). For comparison, near and far VOIs were defined at matched sites in 
the contralateral growth plate. Matched sites in the contralateral growth plate were 
identified by mirroring the contralateral growth plate and registering it to the injured 
growth plate. 
µCT image processing and analysis of bone 
To assess bone bridges, the tissue mineral density (TMD) and bone volume fraction 
(BV/TV) within the growth plate were measured from the pre-incubation scan within a 
manually defined VOI on sagittal slices. In the injured growth plate, this VOI was further 
split into a 0.75mm-diameter VOI at the injury site (“near”) and the rest of the growth 
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plate (“far”). The threshold for segmenting mineralized tissue in all VOIs (531 
mgHA/cm3) was determined using an iterative selection method. (130) 
Comparison of CECT to histology 
2D histological sections were manually registered with the 3D, subtracted µCT images. 
The top and bottom boundaries of the growth plate were defined manually on five 
histological sections per femur at approximately 50µm intervals and at corresponding 
locations on corresponding µCT slices. Growth plate thickness was defined as the 
distance between the top and bottom boundaries of the growth plate in both modalities. 
The histology- and CECT-measured thicknesses were reported as an average of all 
measurements from each limb. The normalized red content was used to represent 
intensity of safranin-O staining. (131) The median red content was computed for a 
24x24µm2 (360x360-pixel2) area at the midpoint between the top and bottom boundaries 
of the growth plate. The median CECT attenuation was computed for a 24x24µm2 (4x4-
voxel2) area centered between the top and bottom boundaries of the growth plate. 
Measurements of zone heights 
Three histological sections near the injury site and three histological sections at an 
equivalent location in the contralateral were selected. The boundary between the resting 
and proliferative zone was defined as the point at which the first flattened chondrocyte of 
the proliferating column appeared, and the boundary between the proliferative and 
hypertrophic zone was defined as the point at which the first round chondrocyte 
appeared. (132) Zone heights were measured at 20 locations per section, and the average 
values for each limb were the averages of these 60 measurements. On each slice, the four 
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measurements adjacent to the injury site (within 0.25 mm of the injury) were designated 
as “near” while all other measurements were designated as “far.” At each location, the 
proportional height of each zone was determined as the fraction of the total growth plate 
height at that location. The average value of proportional zone height for each limb was 
the average of the 60 measurements of proportional zone height. The reliability of zone 
height measurements was assessed by having an independent observer perform 
measurements on a subset of twelve samples (two animals at each time point, injured and 
contralateral). The intraclass correlation coefficient (ICC) with bias and interaction was 
calculated for each zone height: resting (0.88), proliferative (0.78), hypertrophic (0.93), 
total (0.98), proportional resting (0.39), proportional proliferative (0.46), and proliferative 
hypertrophic (0.74). 
Immunohistochemistry 
Immunohistochemistry was performed on subset of samples processed for histology (3 
post-operative day 7, 4 post-operative day 21, 3 post-operative day 42) without antigen 
retrieval.  Slides were treated with peroxidase 1 for 10 minutes, washed with tris-buffered 
saline, and blocked with Rodent Block M for 30 minutes, followed by a second wash 
with tris-buffered saline (Biocare Medical, Concord, CA). Slides were incubated with 
rabbit polyclonal anti-collagen X (1:1000, Abcam, Cambridge, MA, ab58632) for two 
hours at room temperature, followed by rabbit-on-rodent HRP-polymer (Biocare 
Medical, Concord, CA) for 30 minutes at room temperature.  Slides were washed with 
tris-buffered saline, incubated with chromagen dab (3,3’-diaminobenzidine 
tetrahydrochloride) for five minutes, washed with de-ionized water, stained with 
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hematoxylin for three minutes, and washed with tris-buffered saline (Biocare Medical, 
Concord, CA). 
Statistical analysis 
Differences in femur length between injured and contralateral and across time-points 
were determined using a repeated-measures ANOVA with side (injured vs. contralateral) 
as the within-subjects factor and time-point as the between-subjects factor. Differences in 
growth plate thickness and intensity were determined using a repeated-measures ANOVA 
with side (injured vs. contralateral) and location (near vs. far) as the within-subjects 
factors and time-point as the between-subjects factor. Differences in the volume fraction 
and mineral density of bone bridges, and in the height of each of the three zones, were 
determined using a repeated-measures ANOVA with side/location (injured near vs. 
injured far vs. contralateral) as the within-subjects factor and time-point as the between-
subjects factor. When a significant main effect or interaction was found, appropriate post-
hoc tests (Tukey HSD test or pair wise comparison) were performed with appropriate 
Bonferroni corrections. Correlations between histological and CECT measures of the 
growth plate were determined using an ANCOVA with time-point and side (injured vs. 
contralateral) as covariates. 
RESULTS 
Longitudinal growth was disturbed by injury 
Both injured and contralateral femora exhibited longitudinal growth from day 7 through 
day 42 (p<0.0001). However, injured femora were shorter than contralateral femora over 
all time-points (p=0.009; Figure 2.1).  
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Figure 2.1 Length of the injured and uninjured (contralateral) femora, measured from the 
apex of the greater trochanter to apex of the left condyle: The height of each bar 
represents the group mean, and the error bars represent one standard deviation. *p<0.01 
over all time points. 
Thickness was locally increased at the injury site 
The structure of the growth plate defined by CECT qualitatively matched that observed 
with histology (Figure 2.2A). The histologically measured thickness of the growth plate 
was highly correlated to the CECT-measured thickness on corresponding sections 
(R2=0.94, p<0.0001; Figure 2.2B). 
Thickness varied spatially within the growth plate, and over time and was affected 
by injury (Figure 2.2C). Although thickness decreased over time in both regions and 
regardless of injury (p<0.0001), this decrease was least pronounced at the injury site: 
thickness in the near VOI of the injured growth plate was higher than that in the far VOI 
(p<0.0001) and in the near VOI of the contralateral growth plate (p<0.0001; Figure 
2.2D). 
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Figure 2.2 Local thickening of the injured growth plate: A) Top: Sections of the growth 
plate stained with safranin O and fast green. Bottom: Matched CECT slices (bone in 
greyscale, cartilage in color according to attenuation in Hounsfield Units (HU)). Arrows 
indicate the injury site. B) Correlation of histologically and CECT-measured thickness of 
the growth plate (R2=0.94, p<0.0001). Each point indicates the average thickness of one 
sample. C) Maximum thickness projection maps of the growth plate. Arrows indicate the 
injury site. D) Average thickness of the growth plate near to (within 0.5mm) and far from 
the injury site and at matched locations in the contralateral growth plate. The height of 
each bar represents the group mean, and the error bars represent one standard deviation. 
*p<0.0001 vs injured near (across all time points). 
Injury abrogated the age-related decrease in CECT attenuation 
CECT attenuation was elevated with injury in all regions of the growth plate at day 21 
and day 42 (p<0.05; Figure 2.3B). Similar to growth plate thickness, injury mitigated the  
temporal decrease in CECT attenuation. Whereas attenuation progressively decreased 
from day 7 to 21 and 42 in the contralateral VOIs (p<0.0001), no temporal changes were 
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seen in the injured near VOI (p=0.12). In the injured far VOI, attenuation did not differ 
between days 7 and 21 (p=0.65), but was lower at day 42 vs. days 7 and 21 (p<0.0001). 
 
Figure 2.3 CECT attenuation remains high at the injury site: A) Maximum intensity 
projection maps of CECT attenuation in the growth plate. Arrows indicate the injury site. 
B) Average CECT attenuation of the growth plate near to (within 0.5mm) and far from 
the injury site and at matched locations in the contralateral growth plate. The height of 
each bar represents the group mean, and the error bars represent one standard deviation. 
*p<0.0001 vs day 7, #p<0.0001 vs day 21; †p<0.05, ††p<0.005, †††p<0.0001vs 
corresponding VOI in contralateral. 
Bone bridges at injury site have a composition distinct from those outside the injury 
site 
Bone bridges were evident by histology and µCT in all but two samples by day 7, and in 
all samples at later time-points (Figure 2.4A,B). While BV/TV and TMD increased over 
time within both injured and contralateral growth plates (p<0.0001), the TMD of the bone 
within the injury site was higher than in regions far from the injury site and in the entire 
contralateral growth plate by day 21 (Figure 2.4C). BV/TV was higher near the injury site 
compared to far from the injury site and to the entire contralateral growth plate at day 21 
(p<0.01). At all three time points, BV/TV was lower in the injured growth plate far from 
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Figure 2.4 Bone bridge formation. A) 
Histological sections of injured growth 
plate. Arrows indicate disorganized 
chondrocyte columns. Asterisks indicate 
hypertrophic cells. B) Sagittal µCT 
sections of the distal femora containing 
the injured growth plates shown in panel 
A. Arrows indicate bone bridges at the 
injury site. Circles indicate bone bridges 
outside the injury site. C) Bone volume 
fraction (BV/TV) and tissue mineral 
density (TMD) of bone bridges within the 
growth plate. The height of each bar 
represents the group mean, and the error 
bars represent one standard deviation. 
*p<0.01. **p<0.001. D) Matched 
histological section and matched µCT 
section of the injury site at day-7 in a 
sample where the bone bridge has not yet 
formed. Arrows indicates the injury site. 
E) Matched histological section and 
matched µCT section of the injury site at 
day-42 in a sample where the mineralized 
bone bridge is stained with safranin O. 
Arrows indicate the injury site. F) 
Histology and matched CECT of a bone 
bridge formed outside the injury site and 
matched histological section and matched 
µCT section of bone bridges formed in 
the contralateral growth plate and outside 
the injury site. Stars indicate bone 
bridges. 
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the injury site compared to the contralateral growth plate (p<0.01).  
 In day-7 samples with no evident bone bridging, CECT indicated a lack of 
cartilage at the injury site (Figure 2.4D). Histological analysis confirmed the presence of 
fibrous tissue at this site. At later time points, some samples showed safranin-O staining 
at the injury site, while CECT showed the presence of mineralized tissue (Figure 2.4E). 
At days 21 and 42, bone bridges outside the injury site were observed via µCT. However, 
in matched histological sections, these bone bridges were stained with safranin-O rather 
than Fast Green, as was generally observed at the injury site (Figure 2.4F). This staining 
was similar to that of calcified cartilage within the trabeculae immediately proximal to 
the growth plate. 
Figure 2.5 Zone heights A) Height of the resting, proliferative, and hypertrophic zones 
near to the injury site, far from the injury site, and in the contralateral growth plate. B) 
Proportional height of the resting, proliferative, and hypertrophic zones near to the injury 
site, far from the injury site, and in the contralateral growth plate. In both plots, the height 
of each bar represents the group mean, and the error bars represent one standard 
deviation. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
  
Injury disrupts zonal organization within the growth plate 
Disorganized chondrocyte columns were observed adjacent to the injury site at all time 
points. Large, round, hypertrophic chondrocytes were prevalent at days 7 and 21 (Figure  
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2.3B). In injured growth plates, the height of the resting zone was increased relative to 
the contralateral at all time-points (p<0.01; Figure 2.5). Near the injury site, the 
hypertrophic zone height was increased relative to the region far from the injury site 
(p<0.01) and to the contralateral growth plate (p<0.05). While the absolute height of the 
proliferative zone was not affected by injury, the proliferative zone made up a smaller 
proportion of the total growth plate height relative to the contralateral at all time points 
(p<0.0001). This reduced proportional proliferative zone height was due to a combination 
of increased proportional resting (p<0.01) and hypertrophic (p<0.05) zone heights. 
 
Collagen X staining was enhanced near the injury site 
The increased height of the hypertrophic zone was probed further using a molecular 
marker for hypertrophic chondrocytes. In the contralateral growth plate and the injured 
growth plate far from the injury site, collagen X staining was localized to a band specific 
to the hypertrophic zone (defined by cellular morphology) (Figure 2.6B-C). In contrast, at 
the injury site, collagen X staining extended throughout the entire height of the growth 
plate (Figure 2.6A). Small amounts of collagen X staining were also evident within the 
injury site. 
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Figure 2.6 Collagen X immunostaining at day 21. A) Injury site, B) Injured growth plate 
far from injury site, C) Contralateral growth plate. Arrow indicates the injury site. The 
scale bar applies to all three images. 
 
DISCUSSION 
 In this study, the spatially varying response of the growth plate to injury was 
examined to determine how injury impacts the local vs. more remote regions of the 
growth plate. We identified thickening of the growth plate and elevation of CECT 
attenuation near the injury site relative to far from the injury site and to the contralateral 
growth plate. Additionally, both the volume and the mineral density of bone formed at 
the injury site were higher than those of the bone bridges formed outside the injury site 
and in contralateral growth plates. These local changes in the cartilage and bone were 
accompanied by increased hypertrophic zone height immediately adjacent to the injury 
site and decreased proliferative zone height throughout the entire injured growth plate. 
These alterations in growth plate morphology, composition, and cellular activity indicate 
a local dysregulation of endochondral ossification, which may explain the overall global 
disturbance in growth. 
 Since CECT enables simultaneous, three-dimensional visualization of both 
cartilage and bone, this method is a powerful research tool to examine structural and 
compositional consequences of growth plate injury. Magnetic resonance imaging (MRI) 
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has been used clinically to visualize the growth plate cartilage in three dimensions and to 
identify disruptions caused by bone bridges. (22, 133, 134) However, while MRI can 
visualize bony structures, this technique does not capture bone microarchitecture nor 
bone mineral density. Alternatively, standard computed tomography (CT), allows three-
dimensional visualization of the structure and mineralization of bone bridges but is not 
well-suited for imaging cartilage. (135) In contrast, using CECT, it was possible to 
identify a lack of cartilage at the injury site plate at day 7, even in cases where bone 
bridges had not yet formed. Histological examination confirmed the lack of cartilage and 
showed infiltration of the injury site with fibrous tissue. Identification of a defect in the 
early stage of the injury response before bone bridges form suggests that CECT may 
enable early evaluation not possible with conventional µCT. Furthermore, CECT yields 
thickness measurements that were highly correlated with the thickness measured using 
histology, indicating that this method is a reliable means of measuring growth plate 
thickness.  
This study is the first to identify three-dimensional changes in the morphology 
and composition of the cartilage across the entire growth plate following injury. While 
local thickening of the growth plate has been observed qualitatively via histology, (127) 
this study is the first to quantitatively demonstrate a local, persistent change in growth 
plate morphology near the injury site. Other studies where growth plate thickness was 
measured using µCT in the absence of a cartilage-specific contrast agent reported only 
the average thickness of the growth plate. Indeed, it has been shown that injury is 
associated with an overall decrease in growth plate thickness relative to contralateral 
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controls (25, 136) or no change in growth plate thickness relative to age-matched 
controls. (27) Averaging the thickness over the entire growth plate limits the ability to 
detect local changes which may be associated with more subtle growth disturbances. 
Furthermore, the use of age-matched controls, rather than contralateral controls, 
increased power to detect differences using a repeated measures analysis. The increased 
local thickening of the growth plate, paired with overall decreased rate of growth of the 
limb, observed in this study indicates that the mechanisms of growth disturbance involve 
more than simply an overall acceleration of closure of the growth plate.  
Similarly, regions of the growth plate near the injury site maintained a high CECT 
attenuation, indicative of high GAG content, following injury, even while, in general, 
CECT attenuation of the growth plate decreased progressively with age. This persistently 
high CECT attenuation at the injury site over time suggests abnormal proteoglycan 
synthesis. Although, to our knowledge, GAG content of the growth plate has not been 
investigated within the context of aging or injury, researchers have demonstrated that 
GAG content varies zonally, with elevated levels in the hypertrophic zone, according to 
the process of endochondral ossification. (15) This pattern is consistent with our 
observations of increased attenuation and hypertrophy near the injury site. Furthermore, 
GAGs in the growth plate undergo compositional and chemical modifications across the 
zones during endochondral ossification. (17, 18) The local disruption of this ossification 
process seen in the present injury model suggests that spatial variations in GAG structure 
as well as total GAG content could disturb growth.  
 Injury also led to local changes in bone at the injury site. Consistent with previous 
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studies, the amount of bone at the injury site increased from the early osteogenic phase at 
day 7 to the remodeling phase at day 42. (25-27) Bone bridges also formed outside the 
injury site and in the contralateral growth plate, albeit with a lower bone volume fraction 
outside the injury site compared to the contralateral. In contrast, Coleman et al. noted a 
higher bone volume fraction outside the injury site compared to the contralateral, (25) 
and Macsai et al. observed bone bridges only in the injured growth plate. (27) These 
studies differ from the current study in that they used a rat model with a 2 mm drill hole 
injury. The lack of bone bridges observed in the contralateral by Macsai et al. may be due 
to different processes of bone bridge formation in the tibia compared to femur. The 
reduced bone volume fraction outside the injury site compared to controls in this study 
may be due to altered signaling inhibiting age-related bone bridge formation. The 
mechanisms of age-related bone formation are poorly understood; however, in rachitic 
vitamin D receptor-deficient mice, decreased formation of bone bridges, and increased 
height of the hypertrophic zone were noted. (137) It is therefore possible that the reduced 
bone bridge formation outside the injury site may be related to increased hypertrophy at 
the injury site. Bone bridges at the injury site had increased TMD compared to both bone 
bridges outside the injury site and bone bridges in the contralateral physis, indicating that 
bone bridges at the injury site have a different composition from age-related bone bridges 
and may form via a different process. This idea is supported by histological evidence that 
age-related bone bridges tend be stained with safranin-O, while bone bridges formed at 
the injury site do not. However, these observations may instead reflect the fact that bone 
bridges at the injury site formed earlier and therefore had more time to accrue mineral.   
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 The increased thickness near the injury site was accompanied by increased 
hypertrophy at day 7. Disorganized growth plate columns and accumulation of 
hypertrophic cells near the injury site have been observed in other models of growth plate 
injury, particularly at early time points. (25, 31, 32, 125, 127) This local increase in 
hypertrophy is consistent with the collagen X staining observed throughout the entire 
height of the growth plate near the injury site. In contrast to a local, transient increase in 
hypertrophy, proliferation was reduced in the entire injured growth plate. Although 
technical difficulties with carrying out immunohistochemistry following CECT prevented 
successful immunostaining with a proliferative marker, our morphology-based zone 
measurements are in agreement with the work of Macsai et al., who observed a decrease 
in proliferative cells identified by PCNA following injury. (27) This global reduction in 
proliferation may account for the overall slower growth of injured femora, in spite of 
local thickening near the injury site. These local differences in hypertrophy may 
additionally lead to angular deformity, since growth disturbance may not be uniform 
across the growth plate. 
 Since growth plate injury is associated with irregular chondrocyte proliferation 
and hypertrophy, both of which may contribute to disturbance of longitudinal growth, one 
approach to treating growth plate injury would be to target factors that regulate 
chondrocyte proliferation and hypertrophy. Thus far, research has focused on identifying 
therapeutic targets to prevent formation of bone bridges without considering how these 
targets regulate chondrocytes. For example, since VEGF is present at the injury site and 
is critical for the process of angiogenesis that accompanies bone formation, it was 
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hypothesized that inhibition of VEGF would prevent bone bridge formation at the injury. 
(41, 138) However, due to VEGF’s role in the resorption of calcified cartilage of the 
growth plate, VEGF inhibition reduced bone bridge formation but led to an expanded 
hypertrophic zone and reduction in limb length. (126, 139) Additional factors identified 
during growth plate injury that are also regulators of chondrocyte proliferation and 
hypertrophy in the growth plate include the inflammatory factors cycloxyenase-2 and 
interleukin-1b, growth factors fibroblast growth factor and insulin-like growth factor, and 
bone morphogenic proteins. (28, 33-40) Thus, it is important to consider the growth plate 
as a whole when developing therapies. By enabling local and global assessments of both 
bone and cartilage at the growth plate, CECT is a useful tool for these efforts. 
One limitation of this study is that all histology followed CECT scans. The 
extended time at room temperature before formalin fixation may have contributed to 
proteoglycan loss, while incomplete clearance of the contrast agent may have interfered 
with staining. In 30/76 samples safranin-O staining within the growth plate (but not 
within calcified cartilage) was faint, limiting the ability to detect correlations between 
CECT attenuation and red content. While the spatial variation in CECT attenuation 
agreed qualitatively with that in the safranin-O staining in matched 2-D sections, CECT 
attenuation was not correlated with the safranin O staining intensity (measured as red 
content) measured quantitatively in digital images of the histology sections when the data 
from all samples were pooled (R=0.23, p=0.10). Although methods for quantification of 
safranin-O staining have been developed based on the stoichiometric relationship 
between safranin-O and proteoglycans, (131, 140-142) sensitivity of safranin-O to pH, 
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temperature, and exposure time, coupled with low sensitivity to GAGs in proteoglycan-
depleted cartilage, limits the utility of quantification of safranin-O staining. (143) In fact, 
many of the samples with unsuccessful staining were from later time points, where aging 
may contribute to depletion of proteoglycans. However, since CECT attenuation has been 
shown to be correlated to GAG content in articular cartilage, the limitations of 
quantitative measurement of safranin-O staining do not impact interpretation of relative 
changes in CECT attenuation as reflective of relative changes in GAG content. (7, 10) 
Furthermore, the sample processing may have prevented successful 
immunohistochemical staining. In addition to staining for collagen X, we were also 
unsuccessful in staining for markers of proliferation, (proliferating cell nuclear antigen 
(PCNA) and phosphor-histone H3), apoptosis (cleaved-caspase 3), and chondrocyte 
differentiation (parathyroid related protein (PTHrP)). 
 In addition to these limitations with regards to histology, there are limitations with 
regards to the surgical model. A defect in the growth plate does not perfectly recapitulate 
the type of injury seen in the clinic, yet this approach has been used often to study 
formation of bone bridges in animal models. (26, 31) One difference between these 
animal models and the current study is the method for introducing the defect: in other 
studies, the defect is introduced by a drill via a cortical window in the epiphysis, while in 
this study, the defect is introduced by a pin between the femoral condyles after displacing 
the patellar tendon. In spite of these differences, the injury response was similar to that 
seen with drill defects. (26) Additionally, there was no sham experiment to confirm that 
displacement of the patellar tendon did not alter gait in a way that would affect the 
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growth plate, though no abnormalities in gait were noted during the periods of post-
operative care. Finally, the size of the injury may have affected the injury response and 
growth disturbance. In a study of New Zealand White rabbits, an injury affecting 13% of 
the growth plate resulted in no growth disturbance, while an injury affecting 20% of the 
growth plate resulted in shortening of the femur. (125) In this study, the injury site was 
less than 5% of growth plate area, which may explain why injury slowed, but did not 
arrest, growth. 
 In summary, these results indicate that growth plate injury leads to locally 
increased thickness, altered composition, and increased hypertrophy of the cartilage near 
the injury site and increased mineral density within the bone that forms in the injury site. 
These changes were not the same as those occurring more remote to the injury site. This 
spatial variation in the effects of injury may be responsible for non-uniform growth 
disturbances, including angular deformities. Therefore, when developing therapies to 
reduce bone bridge formation, it is important to consider the effects of these treatments 
on the tissues of the remainder of the growth plate. 
 
.
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CHAPTER THREE : THE ROLE OF THE A2B ADENOSINE RECEPTOR IN 
THE DEGRADATION OF BONE AND CARTILAGE IN COLLAGEN 
ANTIBODY-INDUCED ARTHRITIS  
 
INTRODUCTION 
 Rheumatoid arthritis (RA) is an inflammatory autoimmune disease that leads to 
destruction of the bone and cartilage of the synovial joints. In addition to inflammation, 
this disease is mediated by many complex biological processes, including bone turnover, 
cartilage resorption, and angiogenesis. Many of these processes are driven by 
inflammation and involve signaling pathways that are mediated by G-protein-coupled 
adenosine receptors. Of the four subtypes of adenosine receptors, A1 and A3 inhibit the 
release of cyclic AMP (cAMP), while A2A and A2B stimulate the release of cAMP. The 
A2B adenosine receptor (A2BAR) is of particular interest since it is activated by 
pathological levels of adenosine(64) and is highly expressed in synoviocytes of RA 
patients. (144) For these reasons, the A2BAR represents a potential therapeutic target for 
RA. 
 In particular, the A2BAR may modulate disease progression via regulation of 
inflammation. The A2BAR modulates cytokine release in vivo and in vitro by inhibiting 
release of TNF-a (68, 69, 145) and inducing the release of IL-6. (66, 67) Modulation of 
cytokines by the A2BAR may have downstream effects on the other pathways leading to 
destructive changes in RA. For example, TNF-a promotes osteoclastogenesis via 
RANKL, (146) while IL-6 and IL-11 promote osteoclastogenesis via a RANKL-
independent pathway. (53) Similarly, IL-1 induces production of matrix 
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metalloproteinases (MMPs), which contribute to cartilage resorption, (144) while both 
TNF-a and IL-6 induce production of VEGF, which contributes to angiogenesis and 
vascularization of the pannus. (81) Thus, targeting the A2BAR may reduce cytokine-
mediated inflammation and abrogate the destructive effects of inflammation on bone and 
cartilage. 
In addition to cytokine-mediated pathways, A2BAR may also exert a direct 
influence bone turnover, cartilage resorption, and angiogenesis. Upregulation of the 
A2BAR in osteoprogenitor cells and differentiating osteoblasts indicates that the A2BAR 
also directly affects bone cells. (66, 75-77) In fact, stimulation of the A2BAR in 
osteoprogenitor cells is associated with increased mineralization (76, 78, 79)  and 
expression of osteoblastic markers such as ALP, osteocalcin, Runx2, and osterix. (75-79) 
On the other hand, stimulation of the A2BAR inhibited osteoprotegrin (OPG), which itself 
is an inhibitor of osteoclastogenesis, leading to overall reduced OPG/RANKL ratios. (66, 
80) Hence, the role of A2BAR in bone turnover is complex. In addition, the A2BAR plays 
a role in the metabolism of the overlying cartilage. Stimulation of the A2BAR suppresses 
MMP production in vitro, (144) while MMP-9 expression is upregulated in A2BAR KO 
mice with vascular injury. (74) Bone and cartilage destruction may additionally be 
influenced by the formation and vascularization of the pannus. Indeed, stimulation of the 
A2BAR stimulates angiogenesis by enhancing production of IL-8, VEGF, and eNOS. (82, 
83) The involvement of the A2BAR in these key pathways in RA suggests its role in the 
progression of the disease. 
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Animal models can provide mechanistic insight into the influence of adenosine 
receptors in various forms of arthritis. Thus far, study of adenosine receptors in animal 
models of arthritis has been limited to adjuvant arthritis in rats, a model in which arthritis 
is induced by injection of Freund’s adjuvant, a solution of antigen from mycobacteria in 
oil. (147, 148)  Rats treated with the A1, A2A, and A3 adenosine receptor agonists showed 
clinical evidence of reduced swelling, radiographic evidence of bone reduced destruction, 
and histological evidence of reduced cartilage destruction. (84-86) The A2BAR has not 
yet been studied in an animal model of RA.  
The goal of this study was to elucidate the role of the A2BAR in a collagen 
antibody-induced (CAIA) model of RA. We used contrast-enhanced micro-computed 
tomography to simultaneously quantify changes in the bone and cartilage that accompany 
arthritis. We also investigated the contribution of the A2BAR to cellular and molecular 
mechanisms of arthritis by quantifying gene expression and local protein expression.  
 
METHODS 
Animals 
All of the animal experiments were conducted according to a protocol approved by the 
Institutional Animal Care and Use Committee (IACUC) at the Boston University School 
of Medicine in Boston, MA. A2BAR knockout (A2BAR KO) mice were bred onto a 
C57BL/6J background, along with wild-type (WT) mice of the same background. 
		
50 
Figure 3.1 Schematic of tissue collected from mice following induction of arthritis and 
subsequent characterization and analysis 
 
Induction of arthritis 
Arthritis was induced in four-month-old, female mice. Mice were injected with 6.25 mg 
(400µL) of collagen antibody (ArthritoMab, MDBiosciences, St. Paul, MN) on day one, 
followed by 100 µg (100µL) of lipopolysaccharide (LPS, Sigma-Aldrich, Saint Louis, 
MO) on day four. Control mice were injected with saline solution on days one and four. 
Mice were monitored and euthanized if their body weight decreased by more than 20%. 
Mice were sacrificed at day eight or day ten via CO2 asphyxiation, and serum was 
collected immediately. The forepaws and hindpaws were fixed in formaldehyde for 
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routine µCT, histology, and immunohistochemistry (Figure 3.1). The knees were 
harvested and frozen at -80°C for RNA analysis (left) or contrast-enhanced µCT (right). 
Assessment of arthritis 
At day one, day four, day eight, and day ten, mice were evaluated for arthritis. The 
thickness of the hind paws was measured with calipers, and each animal was scored for 
arthritis severity. The arthritis severity was graded on a scale from 0 to 4 for each paw 
and summed: 0 = normal, 1 = swelling of one digit, 2 = swelling of more than one digit, 3 
= swelling of two or more digits and the paw, 4 = severe swelling of the whole paw. 
(149) 
µCT 
The hind paws were scanned using a desktop µCT system (µCT40, Scanco Medical, 
Brüttisellen Switzerland).  An initial scan of the entire paw, including distal portion of the 
tibia and the calcaneus, was performed for qualitative visualization of joint damage (16 
µm/voxel, 70 kV, 114 mA, and 300 ms). Additional scans at a higher resolution (6 
µm/voxel) were performed for quantitative analysis of the 2nd-4th metatarsal-phalangeal 
joint and the 3rd metatarsal midshaft. Volumes of interest (VOIs) were defined manually 
for the cortical bone based on the periosteal and endosteal boundaries of the metatarsal-
phalangeal joint (0.75 mm of the metatarsal and 0.55 mm of the phalange) and the 
metatarsal metaphysis (0.7 mm proximal of the metatarsal head) using the Scanco 
software (Figure 3.3, 3.4). Tissue mineral density (TMD), bone mineral density (BMD), 
and bone volume fraction (BV/TV) were determined in these VOIs. A VOI including the 
cortex of the metatarsal midshaft was defined automatically (Figure XC) and the 
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following parameters were determined in this VOI: TMD, BMD, total areal (Tt.A), 
cortical area (Ct.A), marrow area (Ma.A), and cortical thickness (Ct.Th). For these 
analysis, a threshold of 617 mgHA/cm3 was used. The threshold was determined using 
the adaptive threshold algorithm within the Scanco software. 
CECT 
The knee joints were disarticulated, and femora and tibiae were scanned separately (6 
µm/voxel, 70 kV, 114 mA, and 200 ms) before and after a 14-hour incubation in CA4+ 
(pH 7.3, 28 mgI/mL, 350 mOsm). The portions scanned were the distal-most ~2.5 mm of 
the femur and the proximal-most ~2.3 mm of the tibia, and they included the growth plate 
of each bone. 
Analysis of subchondral bone 
The subchondral bone of the tibiae and femora were analyzed in two rectangular volumes 
of interest (VOIs, 1 mm x 0.5 mm), one medial and one lateral, to examine the 
deterioration of the bones of the knee joint. The trabecular subchondral bone was 
segmented from the subchondral plate using an automatic method. (150) The following 
parameters for the trabecular bone were calculated with a threshold of 669 mgHA/cm3: 
trabecular thickness (Tb.Th), trabecular number (Tb.N), trabecular spacing (Tb.Sp), bone 
mineral density (BMD), and bone volume fracture (BV/TV). The following parameters 
for the subchondral plate were be calculated with the same threshold: thickness, TMD, 
and BV/TV. The threshold was determined using the adaptive threshold algorithm within 
the Scanco software. 
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Image processing of CECT 
Stacks of images from the pre- and post-incubation scans were aligned using an affine 
registration constrained to a rigid body transformation (Amira 5.2.2, Visage Imaging, 
Andover, MA). Cartilage was segmented by applying an upper and lower threshold to the 
post-incubation image. These thresholds were based on a four-part Gaussian fit of the 
intensity histogram of the post-incubation image within the VOI. The post-incubation 
image consisted of four Gaussian distributions with intensities corresponding to noise, 
contrast agent, poorly mineralized bone, and highly mineralized bone. The lower 
threshold was determined such that more than 95% of all voxels with intensities above 
the threshold were expected to be cartilage, while the upper threshold was determined 
such that 25% of all voxels with intensities above the threshold were expected to be bone. 
(121) Next, an erosion was applied to the image to separate the background cartilage 
from background noise and a dilation was applied to restore articular cartilage removed 
during the application of the erosion. The CECT attenuation of the cartilage was 
measured within the rectangular VOIs defined for the subchondral bone analysis. 
Statistical analysis 
For paw swelling, arthritis severity, and body weight, a repeated-measures ANOVA was 
used to identify differences over time and between genotypes and treatments. For all CT 
measurements, a three-way ANOVA was performed to identify differences between 
genotypes, treatments, and time points. To determine relationships between body weight 
and CT measurements at the midshaft, a three-way ANCOVA was performed with body 
weight as the covariate and genotype, treatment, and time points as the factors. 
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Histology and immunohistochemistry 
Following µCT, the forepaws and hindpaws were decalcified in EDTA, embedded in 
paraffin, sectioned, and stained with hematoxylin, fast green, and safranin-O. Based on 
the results of safranin-O/fast green staining, samples will be subsequently processed for 
immunohistochemistry in a future study. Candidates for immunohistochemistry include 
proteins associated with cartilage (Sox9, collagen II, collagen X, aggrecan), proteins 
associated with bone (collagen I, Run2x, osteopontin, osteocalcin), and cytokines (TNF-
α, IL-6). 
RESULTS 
CAIA produces an arthritic response that is unaffected by genotype 
An arthritic condition was observed with CAIA in both genotypes (Figure 3.2A). Paw 
swelling and arthritis scores were increased in CAIA mice vs. controls at all time-points 
(p<0.01) and at each time-point compared to baseline starting on day 8 (p<0.005; Figure 
3.1B,D). CAIA mice also had lower body weight at day 8 (p<0.001) compared to 
controls and had lower body weight compared to baseline at day 8 and day 10 (p<0.0001; 
Figure 3.2C). There was no difference in the arthritic response between genotypes. KO 
mice had an overall higher body weight compared to WT mice (p<0.0001), irrespective 
of CAIA treatment (p=0.18). 
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Figure 3.2 Arthritic response to collagen antibody cocktail. A) Photographs of hind paws 
before and after injection with PBS (control) or collagen antibody cocktail (CAIA). B) 
Body weight of mice. C) Arthritis score for the hind paws. D) Swelling of paws measured 
from baseline using calipers. ***p<0.0001, **p<0.005, *p<0.01 CAIA vs. control at that 
time point. ###p<0.0001, ##p<0.005 CAIA at that time point vs CAIA at day 1. 
CAIA caused minor changes in the bone of the paw near the joint 
No clear effects of CAIA, such as cortical erosion or surface roughening, were observed 
from gross examination of the uCT renderings of the bone of the paw. While there was 
no change in BV/TV in the MTP joint with CAIA (p=0.23) or between genotypes (p-
0.19), BV/TV in the metatarsal metaphysis was higher in KO compared to WT 
(p<0.0001, irrespective of CAIA treatment (p=0.07). TMD was higher in the MTP joint 
in KO compared to WT (p<0.005), irrespective of CAIA treatment (p=0.08). In contrast, 
TMD was higher in the metatarsal metaphysis of control KO mice compared to control 
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WT mice (p<0.01), but there was no difference between genotypes with CAIA (p=0.97). 
Furthermore, TMD increased with CAIA, but only in WT mice (p<0.01). 
Figure 3.3 Changes to bone near the MTP joint with CAIA. A) BV/TV at the MTP joint. 
B) TMD at the MTP joint. C) BV/TV in the metatarsal metaphysis. D) TMD in the 
metatarsal metaphysis. Renderings on the left show MTP and metatarsal metaphysis 
VOIs. *p<0.005, **p<0.0001 vs. WT (pooled over time points and treatments). #p<0.01 
vs. WT control (pooled over time points). Note that the y-axes do not start at zero. 
 
More remote from the MTP joint, at the metatarsal midshaft, there were no 
changes in the cortical bone with CAIA. Instead, there was a phenotypic difference 
between KO and WT mice, with increased Ct.Ar (p<0.05), Tot.Ar (p<0.005), Ma.Ar 
(p<0.01) in with A2BAR ablation (Figure 3.4A-C). These differences in geometry were 
accompanied by an increased pMOI in KO vs WT mice (p<0.005; Figure 3.4E). However 
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there were no differences in BA/TA, Ct.Th, or TMD between genotypes (Figure 
3.4D,F,G).  
Figure 3.4 Changes to cortical bone with CAIA at the midshaft of the third metatarsal. 
A) Ct.Ar. B) Tot.Ar. C) Ma.Ar. D) BA/TA. E) pMOI. F) Ct.Th. G) TMD (note that axis 
does not start at zero). Rendering on the left shows the midshaft VOI. *p<0.05, **p<0.01, 
***p<0.005 vs. WT (pooled over time points and treatments). 
 
Since body weight was also increased in KO mice, the correlation between 
cortical parameters and body weight was investigated to determine whether differences in 
body weight account for differences between WT and KO mice. All parameters that were 
elevated in KO mice (Ct.Ar, Tot.Ar, Ma.Ar, and pMOI) were correlated with body 
weight, while the parameters that were unchanged with genotype (BA/TA, Ct.Th, and 
TMD) were not correlated with body weight (Figure 3.5, Table 3.1). Once adjusted for 
body weight, there was no genotypic difference for any cortical parameter (Table 3.1). 
The relationships between cortical parameters and body weight were not different 
between treatments (p>0.55), genotypes (p>0.55), or time points (p>0.33). 
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Figure 3.5 Relationship between body weight and cortical bone parameters. A) Ct.Ar. B) 
Tot.Ar. C) Ma.Ar. D) BA/TA. E) pMOI. F) Ct.Th. G) TMD. Lines represent a linear 
relationship between body weight and the cortical bone parameter. In cases where body 
weight was correlated to the cortical bone parameter, there was no difference in the 
relationship of this parameter with body weight among experimental groups (treatments, 
genotypes, time points)  
 
Table 3.1 Correlation of cortical bone parameters with body weight based on an 
ANCOVA with body weight as the covariate and treatment, genotype, and duration as 
factors. 
p 
(correlation 
with BW) 
R2 p 
(genotype) 
p 
(interaction 
of BW and 
treatment 
p 
(interaction 
of BW and 
genotype) 
p 
(interaction 
of BW and 
duration) 
<0.0001 0.49 0.93 0.52 0.63 0.51 
0.0003 0.45 0.22 0.77 0.40 0.69 
0.05 0.33 0.97 0.98 0.42 0.49 
0.59 0.27 0.26 0.80 0.30 0.55 
0.0001 0.45 0.38 0.67 0.63 0.51 
0.21 0.25 0.19 0.79 0.15 0.63 
0.89 0.23 0.27 0.29 0.83 0.49 
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CAIA results in bone loss in the subchondral bone of the tibia 
CAIA caused greater changes in the subchondral bone of the tibia. The BV/TV of the 
trabecular bone decreased with CAIA irrespective of genotype (p<0.05), and this bone 
loss occurred due to thinning of trabeculae (p<0.0001), rather than loss of trabeculae 
(p=0.26; Figure 3.6B,E,F). Both BV/TV and Tb.Th decreased from day 8 to day 10, but 
this loss of bone was not restricted to CAIA mice (p<0.001). There were no other 
changes to the trabecular bone microstructure or density with CAIA (p>0.11), but there 
was an increase in DA in KO mice compared to WT mice in both CAIA and control mice 
(p<0.05; Figure 3.6G). Similarly, the BV/TV (p<0.05), thickness (p<0.0001), and TMD 
(p<0.01) of the subchondral plate decreased with CAIA (Figure 5J-L). Moreover, there 
was a progressive decrease in plate thickness with CAIA from day 8 to day 10 (p<0.05). 
Although there was no change in the response of the subchondral plate to CAIA with 
genotype (p>0.05), KO mice had increased subchondral plate thickness and tissue 
mineral density compared to WT mice (p<0.0001). 
CAIA results in reduced CECT attenuation in cartilage 
CECT attenuation in the tibial cartilage decreased at day 8 (p<0.05) and day 10 
(p<0.0001) in both KO and WT mice (Figure 3.7B). However, there was no change in 
cartilage thickness with CAIA (p=0.44) or with treatment (p=0.14) for either genotype. 
Sagittal CECT sections show that CECT attenuation following CAIA treatment was 
lower particularly in the superficial zones of the articular cartilage (Figure 3.7A). 
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Figure 3.6 Changes to subchondral bone of the tibia. A) Subchondral trabecular bone 
(orange) and subchondral plate (purple) VOIs. B) Trabecular BV/TV. C) Conn.D. D) 
SMI. E) Tb.N. F) Tb.Th. G) Tb.Sp. H) DA. I) Plate TMD. J) plate BV/TV. K) Plate 
thickness. L) Plate TMD. *p<0.05, **p<0.001, ***p<0.0001 CAIA vs control. #p<0.001, 
##p<0.0005 day 10 vs day 8. +p<0.05, ++p<0.0001 KO vs. WT. †p<0.05 day 10 CAIA 
vs. day 8 CAIA. Note that some axes do not start at zero 
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DISCUSSION 
In this study, the role of the A2BAR in the degenerative changes in bone and 
cartilage associated with CAIA was examined. An arthritic condition was observed in 
CAIA mice of both genotypes, and no difference in the effects of CAIA was found 
between genotypes. CAIA induced minimal changes to the bone of the paw, but clear 
bone loss in both the trabecular subchondral bone and the subchondral plate of the tibia, 
but there was no difference in response of bone to CAIA with genotype. Additionally, the 
tibial cartilage demonstrated a decrease in CECT attenuation with CAIA, but no 
difference between genotypes. Overall, these results indicate that the A2BAR did not 
influence the progression of CAIA at the level of bone and cartilage degradation. 
Figure 3.7 Destruction of cartilage with CAIA. A) Sagittal CECT sections of the 
proximal tibia. Insets show a closer view of the cartilage. B) CECT attenuation of the 
tibia articular cartilage C) Thickness of the tibia articular cartilage. *p<0.0005, 
**p<0.0001 CAIA vs control. 
 Swelling of the paws occurred with CAIA irrespective of genotype, suggesting 
that ablation of the A2BAR does not affect the gross inflammatory response. Assays of the 
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serum collected in this study will indicate whether ablation of the A2BAR impacts TNF-a 
release in the context of CAIA. Although TNF-a levels are elevated in A2BAR KO 
macrophages at baseline, a non-specific adenosine receptor agonist is capable of 
suppressing LPS-induced TNF-a release in A2BAR KO macrophages, indicating that 
TNF-a release is also mediated by other adenosine receptors. (67) Similarly, the ability 
of a non-specific adenosine receptor agonist to inhibit LPS-induced release of TNF-a and 
IL-8 by synoviocytes is blocked by A2A and A3 antagonists, but not A1 or A2B 
antagonists, providing further evidence that the other adenosine receptors provide an 
alternative inflammatory pathway in the absence of the A2BAR. (151) A1-, A2A- and A3-
specifc agonists also prevent or reduce swelling or arthritis score in arthritis models, 
indicating that these receptors may mitigate detrimental effects of A2BAR KO on 
inflammation. (84-86, 152-154) The involvement of other receptors in the inflammatory 
response may explain why ablation of the A2BAR alone did not affect the swelling 
response to CAIA. 
The greatest degenerative changes with CAIA were in the tibial cartilage. A 
reduction in cartilage CECT attenuation, but not cartilage thickness, indicates a loss of 
GAG, (7) but not cartilage tissue. Degradation of GAG in the cartilage matrix in RA is 
mediated by a combination of aggrecanases and MMPs. (155) Increased expression of 
MMPs and decreased expression of cartilage matrix proteins contribute to increased 
GAG loss in arthritis, and these changes in gene expression are accompanied increased 
expression of the A2AAR. (156) Although adenosine receptors have not been shown to 
have an influence on aggrecanases, these receptors do influence release of MMPs. Initial 
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experiments showed that a general adenosine receptor agonist, but not A1-, A2A-, or A3-
specific agonists, suppressed production of collagenase by IL-1 in synoviocytes, 
implicating the A2BAR. (144) This result indicates that loss of the A2BAR would lead to 
degradation of cartilage; however, we found no difference in CECT attenuation or 
cartilage thickness between the two genotypes. The lack of difference between genotypes 
may be due to compensation by other adenosine receptors. In vitro, an A2A agonist 
reduced adenosine deaminase-induced release of GAG and reduces phorbol myristate 
acetate-induced release of MMPs. (72, 157) Similarly, an A2A agonist abrogates the 
reduced safranin O staining and GAG content caused by septic arthrosis. (85, 152) The 
contribution of the A2AAR to suppression of MMP release indicates that effective RA 
therapies may require targeting a combination of adenosine receptors. 
While there were minimal changes in the bone of the paw with CAIA, and these 
changes were not impacted by genotype. However, there were differences in bone 
phenotype between KO and WT mice. Near the joint, the bone of KO mice had increased 
TMD and BV/TV, while far from the joint, the bone of KO mice was larger in cross-
section. This finding was surprising, given the role of the A2BAR in osteoblastogenesis. 
(75, 76) Furthermore, a previous study of male A2BAR KO mice found that the cortical 
bone of the femur has reduced Ct.Th, BV/TV, and TMD. (79) This discrepancy may be 
due to sex differences, but there have been no studies yet reporting differences between 
male and female A2BAR KO mice. The increased cross-sectional area of bone in KO 
mice was accompanied by increased body weight; therefore, it is possible that the 
genotypic differences in cross-sectional area are due to adaptation to increased body 
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weight, rather than differences in bone remodeling. Indeed, all measures of cross-
sectional area were correlated with body weight. This relationship between cross-
sectional size of limb bones and body weight has been observed across and within many 
inbred mouse strains. (158-160) In addition to the genotypic differences in the paw, there 
was also increased DA of the subchondral trabecular bone and increased thickness and 
TMD of the subchondral plate. In the previous study of male A2BAR KO mice, there 
were no changes in the BV/TV, Tb.N, and Tb.Th of the trabecular bone of the metaphysis 
with genotype, as observed in trabecular subchondral trabecular bone with this study, but 
DA was not reported. (79) TRAP staining in the paw and measurement of expression of 
markers of bone formation and resorption will reveal whether ablation of the A2BAR also 
resulted in a disruption of bone remodeling. 
Although there was swelling of the paws with CAIA, there were no visible 
changes to the bone at this site. In the late stages of CIA, there are often obvious changes 
in the gross morphology of paws, including surface roughening and cortical bone loss at 
the joints. (161-163) However, at earlier time-points, there may be no change in the gross 
morphology of the bone, despite swelling of the paws. (163) While CAIA generally has a 
more rapid onset than CIA, the time-points in the present study may be within the early 
stage of the disease preceding bone loss. (61) The only change observed with CAIA was 
increased TMD in the metatarsal metaphysis of WT mice. Increased TMD with CAIA is 
surprising, since BMD is often decreased at this site in animal models of arthritis, even at 
early time-points. (91, 164) On the other hand, there were no changes with CAIA in the 
cortical bone more distant from the joint, which is consistent with findings that cortical 
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bone is not affected by CAIA (165) and with the observation that surface roughening and 
cortical bone loss is generally concentrated at the joints. (161-163)  
In contrast to the small changes observed in the paw, there were more severe 
changes to the bone of the tibia. CAIA led to bone loss via thinning of subchondral 
trabeculae and thinning of the subchondral plate, a phenomenon that has been observed 
both in AIA and CIA. (166, 167) While CAIA led to increased TMD in the metatarsal 
metaphysis, there was instead decreased TMD in the subchondral plate. The differences 
observed between the sites may reflect a difference in severity between these sites or a 
difference in the detection limits at these sites due to differences in the size of the bone. 
On the other hand, the difference between sites may also reflect a difference between the 
response of cortical bone (measured both at the paw and tibia) and that of trabecular bone 
(measured only at the tibia). In fact, it has been observed that bone loss with CAIA is 
more severe in the trabecular bone than in cortical bone. (165) 
In summary, this study indicates that the A2BAR does not independently influence 
the swelling, subchondral bone loss, or compositional changes in cartilage associated 
with CAIA. While ablation of the A2BAR did result in a distinct bone phenotype, this 
phenotype is associated with increased body weight in A2BAR KO mice, and this 
phenotype did not lead to a change in the response to CAIA. Although the A2BAR 
influences many pathways relevant to rheumatoid arthritis, the results of this study, 
alongside evidence from the literature, indicate that other adenosine receptors, 
particularly the A2AAR, provide an alternate pathway in the absence of the A2BAR. To 
better understand the role of adenosine receptors in general, it will be necessary to design 
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studies that examine the interactions between adenosine receptors and identify how one 
receptor may compensate when another is inhibited. These studies may provide further 
evidence that rheumatoid arthritis requires a combinational approach targeting multiple 
adenosine receptors in concert.
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CHAPTER FOUR : ABILITY OF CONTRAST ENCHANCED MICRO-
COMPUTED TOMOGRAPHY TO PREDICT THE STIFFNESS OF THE 
CARTILAGINOUS FRACTURE CALLUS 
 
INTRODUCTION 
Bone has a rare capacity for repair following injury. Fracture healing in long 
bones normally consists of four phases: inflammation, formation of a cartilaginous callus, 
replacement of the cartilaginous callus with a bony callus, and remodeling of the bony 
callus to restore the bone’s original shape and structure. (95) During this process, the 
stiffness and strength of the callus are recovered. (98) Identifying the point in time at 
which stiffness and strength have adequately recovered is critical for physicians when 
advising patients to return to normal weight bearing. Furthermore, 12% of patients 
experience impaired healing or non-union, and the ability to identify these cases early on 
may improve outcomes. (99) Early identification of cases of poor healing almost 
certainly requires the ability to monitor the formation and resorption of cartilage, because 
of the initial role this tissue plays in providing stability across the fracture gap and the 
later role it has in providing a template for endochondral formation of bone. (101, 168) 
 Clinical imaging is a promising approach for non-invasive assessment of 
mechanical function of the callus. While radiographs are considered a gold standard, 
there is only moderate interobserver agreement (measured by Cohen’s kappa for chance-
corrected agreement) among orthopaedic surgeons in ratings of fracture healing using the 
semi-quantitative scale developed by Hammer et al.  (k=0.60) (169) and slightly greater 
agreement in determination of the number of cortices bridged by callus (k=0.75).(108) 
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Since cortical bridging showed the greatest interobserver agreement, the Radiographic 
Union Score for Tibial fractures (RUST) was developed to standardize fracture healing 
assessment (intraclass coefficient= 0.86), (109), and software has been developed to 
automate the detection of cortical bridging. (110) While use of RUST has standardized 
assessment of fracture healing, the ability of RUST predict the stiffness and strength of 
the callus has yet not been assessed. On the other hand, it has been found that density 
measured from radiographs is not correlated to failure load. (113) Computed tomography 
(CT) in contrast, provides three-dimensional, quantitative information about bony callus 
composition and geometry that has been associated with the stiffness of the callus. 
Measures of the mineral density from CT, in particular, are positively correlated to 
strength and stiffness in both bending and torsion. (112, 114-116, 118) In contrast, 
measures of callus size, including volume and area, are negatively correlated with 
bending stiffness and strength. (112, 118) CT-based structural rigidity analysis combines 
information about density and geometry obtained by CT to enable predictions of callus 
torsional stiffness. (115) 
CT-imaging can be combined with measurements of tissue-level stiffness for 
improved estimates of callus stiffness. At the tissue level, the indentation modulus of 
osseous, cartilaginous and fibrous tissue has been measured using nanoindentation, and it 
was found that, for osseous tissue, mineral density is correlated with the indentation 
modulus. (170, 171) Combining geometry from CT scans with tissue-level properties 
from nanoindentation, finite element models can be used for more sophisticated 
predictions of callus torsional stiffness. (119, 172) While these models differentiate 
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between mature and newly formed bone based on tissue mineral density, they do not 
differentiate between cartilage and other soft tissue. 
One limitation of conventional CT is that it does not enable estimates of 
mechanical properties during the early stages of bone healing that are dominated by the 
cartilaginous callus. Contrast-enhanced computed tomography (CECT), however, relies 
on electrostatic interactions between a contrast agent and glycosaminoglycans (GAG), 
allowing quantitative imaging of cartilage. (6) Moreover, CECT attenuation is correlated 
to both the GAG content and the compressive modulus of articular cartilage, suggesting 
that CECT parameters may be predictive of callus stiffness. (7) While CECT has been 
used to quantify the composition and geometry of the fracture callus, it has not yet been 
applied alongside mechanical testing. (120, 121) 
The goal of this study was to assess the ability of CECT to predict the mechanical 
response of the cartilaginous fracture callus. The specific objectives were: 1) to determine 
whether the compressive stiffness of the whole callus can be predicted by the geometry 
and CECT attenuation; and 2) to determine whether the tissue level stiffness of the 
cartilage tissue measured by indentation can be predicted by CECT attenuation. 
METHODS 
Animal model 
All of the animal experiments were conducted according to a protocol approved by the 
Institutional Animal Care and Use Committee (IACUC) at the Boston University School 
of Medicine in Boston, MA. Simple, closed, transverse, stabilized femoral fractures were 
generated in the femur of 25 male, eight-week-old C56B/6J mice (Jackson Labs, Bar 
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Harbor, ME). (173, 174) Mice were euthanized via carbon dioxide asphyxiation. The 
musculature was removed with care to leave the soft callus intact. Once extracted, the 
entire femur, inclusive of the callus was frozen at -80°C. Sixteen calluses were excluded 
for one of several reasons (ten comminuted or displaced fractures, one damaged during 
harvest, one damaged during scanning, four damage during mechanical testing), leaving 
n=9 samples for analysis. 
CECT 
Fracture calluses were scanned in phosphate buffered saline (PBS) using a desktop µCT 
system (µCT40, Scanco Medical, Brüttisellen Switzerland; 12µm/voxel, 70 kV, 114 mA, 
and 200 ms). Scans were performed before (pre-incubation) and after (post-incubation) 
incubation in a solution of CA4+ (27 mg iodine/mL, pH 7.4, 350-450 mOsm), 0.05 
mg/mL penicillin, 0.05 mg/mL streptomycin, 0.1 mg/mL neomycin (Fisher Scientific, 
Pittsburgh, PA) and protease inhibitor (1 tablet per 40 mL, Roche Diagnostics 
Corporation, Indianapolis, IN) for 8 hours. (6)  
Stacks of images from the pre- and post-incubation scans were aligned using an 
affine registration constrained to a rigid body transformation (Amira 5.2.2, Visage 
Imaging, Andover, MA). The pre-incubation image was subtracted from the post-
incubation image, and cartilage was identified on the subtracted image by applying a 
sample-specific threshold (lower = 2021-2728 NU, upper = 2521-3864 NU). This 
threshold was determined by fitting  four Gaussian distributions, corresponding to noise, 
PBS, cartilage, and bone, to the intensity histogram of the subtracted image. (120)  
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A manual volume of interest (VOI) for the callus was defined by tracing the outer 
boundary of the callus on transverse sections of the post-incubation image. Within this 
VOI, bone volume, bone volume fraction, and tissue mineral density were determined 
from the pre-incubation image (threshold = 624 mgHA/cm3), and callus volume, cartilage 
volume, cartilage volume fraction, and CECT attenuation were determined from the 
subtraction image. Callus area and cartilage area were also measured on transverse 
sections within this VOI at 250µm intervals within 1500 µm of the fracture gap. (120) 
Compression testing 
Following CECT scanning, calluses were incubated in saline for 24 hours to clear the 
contrast agent. Calluses were potted in 12mmx12mm aluminum cubes filled with 
polymethyl methacrylate (PMMA) and loaded into custom-built fixtures on the uniaxial 
testing machine outfitted with a 10N load cell (Instron 5565, Instron, Norwood, MA).  
Calibration tests were conducted to calculate the system stiffness, where the “system” 
was defined as the load frame, fixtures, and PMMA (155.1-365.2 N/mm, median=209.8), 
and to ensure that the fixtures were aligned with each other (within ±3°) to produce 
uniaxial loading. The system stiffness was calculated by testing 10 low density 
polyethylene (LDPE) samples (McMaster-Carr, Elmhurst, IL) of known stiffness (220-
274 MPa, diameter = 6.35 mm, length = 11.8 ± 0.8 mm). LDPE samples were potted in 
PMMA and underwent five pre-conditioning cycles, each to a peak load of 3 N, followed 
by final loading ramp to 5 N at a rate of 0.05 mm/s. For each LDPE sample, the slope 
was measured at nine-point segments of the load-displacement curve and the maximum 
slope was used to calculate system stiffness according the following equation: 
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𝑘"#" = %&'()%*+,-%&'().%&'() 	(Equation 4.1) 
where ksys is the system stiffness, kLDPE is the known stiffness of LDPE, and kmeas is the 
slope measured from the load-displacement curve. 
Calluses underwent five pre-conditioning cycles, each to a peak load of 3 N, 
followed by final loading ramp to 5 N at a rate of 0.05 mm/s. The slope was measured at 
nine-point segments of the load-displacement curve and the maximum slope was used to 
calculate stiffness according the following equation: 𝑘12 = %-3-%*+,-%-3-.%*+,- (Equation 4.2) 
where kca is the callus stiffness. The callus stiffness was calculated using the median 
system stiffness, and error bars were reported based on the minimum and maximum 
system stiffness.  
 The force, displacement, and modulus were scaled based on the size of the callus 
to calculate the effective stress, strain, and modulus, respectively. The effective stress 
(seff) was calculated based on the measured force (F) and the average area (A) of the 
callus measured using µCT within 1500 µm of the fracture gap: 𝜎566 = 78(Equation 4.3) 
The effective strain (eeff) was calculated based on the displacement (d) and the length (L) 
of callus measured from the CECT scans: 𝜀566 = :;(Equation 4.4) 
The effective modulus (Eeff) was calculated based on the stiffness, length, and area of the 
callus: 
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𝐸566 = %=,;8 (Equation 4.5) 
Cryosectioning 
Following compression testing, the fracture callus was embedded in optimal cutting 
temperature (OCT) freezing medium (Fisher Scientific, Pittsburgh, PA). The OCT 
freezing medium was frozen in an isopentane bath cooled with liquid nitrogen and stored 
at -80°C. Alternating sections of 7µm and 150µm thickness were cut using a tungsten-
carbide blade (Delaware Diamond Knives, Wilmington, DE) at an angle of 16° and a 
temperature of -23°C (HM 525, Microm, Richard-Allan Scientific, San Diego, CA). For 
thick sections, the tissue was supported with adhesive tape during sectioning and fixed to 
the slide with cyanoacrylate glue. For thin sections, the tissue was retrieved from the 
block using a brush and immediately fixed on the slide for 5 minutes in 95% ethanol. 
Histology 
The 7µm-thick sections were decalcified on the slide in 14% EDTA for 5 minutes and 
stained with a standard safranin-O/fast green protocol or with safranin-O only. From 
safranin-O stained sections, proteoglycan content was estimated based on the red content. 
(131) 
Nanoindentation 
Prior to indenting on callus tissue, the machine compliance was calculated (4.07 nm/mN) 
by completing three six-by-six arrays of indents (5000-9500µN) on a fused quartz 
standard sample using a sharp Berkovich tip (Triboindenter 900, Hysitron, Minneapolis, 
MN). After a 50-µm-diameter sapphire flat-punch was installed, a tip-to-optics 
calibration was performed using a wax sample. A daily z-axis calibration was performed 
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to monitor the zero-force gap (91.03 ± 1.28 µm) and electrostatic force (0.02738 ± 
0.00007 µN/V2). The 150-µm-thick sections were immersed in a solution of de-ionized 
water, 0.05 mg/mL penicillin, 0.05 mg/mL streptomycin, 0.1 mg/mL neomycin (Fisher 
Scientific, Pittsburgh, PA) and protease inhibitor (1 tablet per 40 mL, Roche Diagnostics 
Corporation, Indianapolis, IN) during nanoindentation testing to prevent dehydration and 
degradation of the sample.  
 
Table 4.1 Callus samples with fewer than 25 indents (five indents on five sections). 
SAMPLE NUMBER 
OF 
SECTIONS 
NUMBER 
OF 
INDENTS 
SECTION 1: 
NUMBER 
OF 
INDENTS 
SECTION 2: 
NUMBER 
OF 
INDENTS 
SECTION 3: 
NUMBER 
OF 
INDENTS 
SECTION 4: 
NUMBER 
OF 
INDENTS 
SECTION 5: 
NUMBER 
OF 
INDENTS 
32 4 18 5 5 5 3  
34 5 23 5 5 5 5 3 
35 3 14 5 5 4   
38 5 23 5 5 5 5 3 
39 4 13 5 5 2 1  
 
Indents were performed on cartilage of the callus using a 50-µm-diameter sapphire flat-
punch tip in displacement control with a peak displacement of 4000 nm, a loading rate of 
2000 nm/s, a hold time of 5s, and an unloading rate of 2000 nm/s. For each callus, up to 
five indents were performed on the cartilage of up to five sections per callus. In some 
four calluses, there was a small amount of cartilage, and it was not possible to perform 25 
indents (Table 4.1). This quantity of indents was determined based on pilot studies which 
indicated that the mean indentation modulus (Er) and standard error of the mean were 
stable with a minimum of five indents. The indentation modulus was derived from the 
unloading curve according to the Oliver-Pharr method: (175) 
𝐸> = 2 @A8= (Equation 4.3) 
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Where S is the unloading stiffness and Ac is the contact area. For a flat-punch indenter, 
the contact area is constant. 
 
Statistical Analysis 
Correlations between callus stiffness and CECT parameters were identified using 
Spearman’s rank correlation coefficient (r). For correlations between indentation 
modulus, CECT attenuation, and red content, the average values of each section were 
used. A non-parametric ANCOVA was performed on the ranks with sample as a random 
factor. 
RESULTS 
Prediction of whole callus stiffness of CECT 
The force-displacement curves of the callus showed a toe region, followed by a 
linear response until loads of 3N, enabling measurement of callus stiffness (Figure 4.1A). 
After normalizing for callus size to calculate the effective stress and strain, the set of 
calluses do not collapse into a single curve (Figure 4.1B). Indeed, the coefficient of the 
variation of the effective modulus (0.91) is greater than the coefficient of variation of the 
stiffness (0.56). Instead, the curves appear to segregate into two groups: one with a higher 
effective modulus (callus 32, 39) and a second with a lower modulus (21, 30, 34, 35, 36, 
38). When the two high effective modulus calluses are excluded, the coefficient of 
variation of the stiffness is reduced to 0.36, while the coefficient of variation of the 
effective modulus is reduced to 0.33. However, normalizing the stiffness based on callus 
size does not greatly affect the coefficient of variation.  	
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Figure 4.1 Load curves of fracture callus subjected to compression: A) Force-
displacement curves of all calluses in the study; B) Effective stress-strains curves. Stress 
is calculated based on the average cross-sectional area measured by µCT, while strain is 
calculated based on the length of the callus. 
CECT imaging demonstrated that at this early time point, there was no cortical 
bridging across the fracture gap; rather, bone formation was restricted to the distal and 
proximal portions of the callus (Figure 4.2). Cartilage often did not span the fracture gap 
and instead formed two separate volumes, one distal to and one proximal to the fracture 
gap. In many cases, the callus was asymmetrical, with more cartilage forming anteriorly 
than posteriorly. 
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Figure 4.2 Images of the fracture callus: A) 3D rendering of the callus (bone in white and 
cartilage in pink); B) Histological section of the callus (safranin O and fast green); C) 
Corresponding CECT section (bone in greyscale, cartilage in color map). Scale bar refers 
to both histological and CECT sections. 	
The stiffness of the callus was best predicted by the geometry of the soft tissue, 
including the callus volume (r=-0.78, p =0.02) and area (r=-0.72, p =0.023, Figure 4.3). 
While the bone volume (p=0.05) and bone volume fraction (p=5.43) were not correlated 
to callus stiffness, the TMD was negatively correlated to callus stiffness (r=-0.92, p 
=0.0005). In contrast to measures of bone geometry, measures of cartilage geometry, 
including cartilage volume (r=-0.92, p =0.0005), cartilage volume fraction (r=-0.82, p 
=0.007), and cartilage area (r=-0.83, p =0.005) were negatively correlated with callus 
stiffness. However, the CECT attenuation of the callus was not correlated with callus 
stiffness (r=-0.07, p =0.86). 
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Figure 4.3 Correlations of CECT parameters with callus compressive stiffness. A) Callus 
Volume, B) Bone Volume, C) Bone Volume Fraction, D) Tissue Mineral Density, E) 
Cartilage Volume, F) Cartilage Volume Fraction, G) Callus Area, H) Cartilage Area. 
Spearman’s r is reported. Error bars show the minimum and maximum values of stiffness 
based on uncertainty in the system stiffness. 
The stiffness for each callus was normalized by the average cross-sectional area 
of the callus and the length of the callus measured by µCT to find an effective modulus. 
This effective modulus was correlated to all of the geometric measures that were 
correlated with callus stiffness (Figure 4.4A,B,F,G,H). However, even with the 
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normalization for callus size, CECT attenuation was not correlated to effective modulus 
(r=-0.07, p =0.86; Figure 4.4I). 
Figure 4.4 Correlations of CECT parameters with callus effective compressive modulus. 
A) Callus Volume, B) Bone Volume, C) Bone Volume Fraction, D) Tissue Mineral 
Density, E) Cartilage Volume, F) Cartilage Volume Fraction, G) Callus Area, H) 
Cartilage Area. Spearman’s r is reported. Error bars show the minimum and maximum 
values of modulus based on uncertainty in the system stiffness. The effective modulus is 
calculated from the stiffness based on the average cross-sectional area and length 
measured by µCT. 
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Prediction of tissue stiffness of callus cartilage by CECT 
The indentation load curves exhibited a reproducible shape that was consistent 
with that expected for a soft tissue such as cartilage (Figure 4.5A). For high-stiffness 
indents, the slope of the unloading curve was initially quite high and then decreased, 
while in medium- and low- stiffness indents had a more constant unloading slope.   The 
indentation modulus measured by nanoindentation showed a great deal of variation 
between samples, between sections, and within sections (Figure 4.5B)  
Figure 4.5 Indentation of the fracture callus. A) Representative force-displacements 
curve for indents on callus cartilage. All indents are from a single callus and represent 
high- (90th percentile), medium- (50th percentile) and low- (10th percentile) stiffness 
indents). B) Indentation modulus measured on 9 callus samples, each with 3-5 indents on 
3-5 sections. Each point represents a single indent. Indents from different sections are 
represented by different colors. 
Similar to indentation modulus, both CECT attenuation and red content 
demonstrated a great deal of within-section variation and spatial heterogeneity (Figure 
4.6). CECT attenuation was not correlated with red content of sections stained with 
safranin O (p=0.52), and the indentation modulus was not correlated with either CECT 
attenuation (p=0.24) or red content (p=0.40; Figure 4.7). 
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Figure 4.6 Variation in red content and CECT attenuation from two sections each from 
two representative samples. A,C) CECT section and corresponding histogram of CECT 
attenuation. B,D) Histological section stained with safranin O and corresponding 
histogram of red content. Scale bar refers to all images and color bar refers to all CECT 
images. Grey line on histogram represents the mean value of CECT attenuation or red 
content. 
DISCUSSION 
In this study, the ability of CECT-measured attenuation and callus geometry to 
predict both the compressive stiffness of the fracture callus and the indentation stiffness 
of the cartilaginous tissues of the callus was assessed. It was found that callus stiffness 
		
82 
was negatively correlated to callus cross-sectional area and the amount of cartilage, but 
was not correlated with the amount of bone. Neither callus stiffness nor indentation 
stiffness was correlated with CECT attenuation. 
Figure 4.7 Correlation of indentation modulus with estimates of GAG content of 
cartilage of the callus. A) Correlation between CECT attenuation and red content of 
safranin O stained sections. B) Correlation between indentation modulus and CECT 
attenuation. C) Correlation between red content and indentation modulus. Each point 
represents the average value for a given section, and each error bar represents the 
standard deviation of the values for that section. 
 
 Our finding that callus volume and area are negatively correlated to the 
compressive stiffness and effective modulus of the callus is consistent with other studies 
that have shown that callus area is negatively correlated with bending stiffness and callus 
volume is negatively correlated with bending strength. (112, 118) Since callus volume is 
also negatively correlated to TMD, it has been hypothesized that large calluses have 
inferior mechanical properties because they are poorly mineralized. (116) Surprisingly, 
TMD was negatively correlated with compressive stiffness in this study, despite previous 
evidence that TMD and BMD are typically positively correlated with bending and 
torsional stiffness and strength. (112, 114-116, 118) However, the time-point in this study 
is much earlier than those used in other studies, preceding cortical bridging across the 
fracture gap, so it is expected that mineralized tissue would contribute little to the 
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compressive stiffness. Indeed, neither the bone volume, nor the bone volume fraction, 
was correlated with compressive stiffness. While bone may not directly contribute to the 
mechanical response of the callus at this time point, it is possible that the negative 
association with TMD is due to the fact that TMD may be a marker of other factors, such 
as maturity of the callus. 
The amount of soft tissue (cartilage volume, cartilage volume fraction, and 
cartilage area) was negatively correlated with compressive stiffness and effective 
modulus. When a fracture is poorly stabilized, a large callus with a large amount of 
cartilage forms in compensation, and the resulting callus is often less stiff that more 
rigidly stabilized fractures. (96, 176) It is also possible that the type of fracture 
(transverse vs oblique) may impact the type of interfragmentary motion that occurs at the 
fracture gap and affect healing response. Oblique fractures lead to formation of larger, 
less stiff calluses compared to transverse fractures. (177) Furthermore, finite element 
models suggest that calluses may form in an asymmetric manner to compensate for 
oblique fractures. (178) Asymmetry across the fracture gap (distal vs. proximal) may 
additionally reflect the original asymmetric development process. (179) Therefore, the 
observation of a large, highly cartilaginous callus via CECT may be indicative of an 
inadequately stabilized fracture. CECT observations could aid in the decision-making 
process, allowing physicians to intervene and increase stability of the callus to improve 
outcomes.  
There was no correlation between CECT attenuation and callus stiffness or 
effective callus modulus, and there was no correlation at all between indentation stiffness 
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and either CECT attenuation or red content. However, in this study, indentation modulus, 
CECT attenuation, and red content were averaged over 150µm-thick sections, and the 
amount of variation within those sections approached the amount variation between 
sections. It is likely that both cartilage stiffness and GAG content vary on a length scale 
that could not be captured by this study design. The lack of relation between indentation 
modulus and CECT attenuation is surprising, since CECT attenuation of this cationic 
contrast agent has typically been positively correlated with the compressive modulus of 
articular cartilage. (7, 11-13) This discrepancy may also be due to the fact that articular 
cartilage has a distinctly different organization and composition from the cartilage of the 
callus. (180, 181) Although the GAG content of articular is depth-dependent, spatial 
variation of GAG content within the plane tested may be less than in the fracture callus, 
leading to a more robust relation between CECT attenuation and compressive modulus. 
In addition to different spatial variations in GAG content, there may be different amounts 
of, and organization of, the cartilage. 
In addition to being different from articular cartilage, the organization and 
composition of the cartilage of callus changes throughout the healing process.  For 
example, in this study, we found a lower indentation modulus of cartilage and greater 
variation indentation modulus than Leong et al found for the callus tissue of the rat. (170) 
This difference in measured indentation modulus may be due to the fact that Leong et al 
tested calluses in the late stages of fracture healing, while we tested calluses in the early 
stages of fracture healing. In the early stages of callus formation, the collagen network is 
highly disordered and becomes increasingly aligned with the loading direction as fracture 
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healing progresses. (181) The orientation of collagen fibers has been shown to influence 
the tissue-level mechanical response of cartilage. For example, repair tissue in an 
articular cartilage defect has both a more random orientation of collagen fibers and a 
lower indentation modulus compared to healthy articular cartilage. (182, 183) Similarly, 
indentation of the superficial zone of the cartilage in the transverse and longitudinal 
directions indicates that the organization of collagen contributes to an anisotropic 
response. (184) Since collagen appears to play an important role in the tissue-level of 
cartilage, it may be useful to use additional techniques such as Fourier-transform infrared 
spectroscopy and polarized light microscopy to determine the quantity and organization 
of collagen in the callus. It is possible that variation in collagen content and organization 
may explain some of the variation in tissue-level stiffness that cannot be explained by 
variation in GAG content. 
An additional challenge in predicting callus stiffness directly from CECT is the 
heterogeneity and asymmetry of the callus. The callus is composed of various tissues 
with quite different tissue-level moduli, and it is likely that their arrangement space is 
more predictive of callus stiffness than their relative amounts. One promising approach 
would be to voxel-based FE models that use CECT to distinguish between cartilage, non-
cartilaginous tissue, newly formed bone, and highly mineralized bone may provide 
improved estimates of callus stiffness. With in vivo CECT, it would be possible to 
develop patient-specific models that estimate the stiffness of the callus at various points 
throughout the fracture healing process. 
The changes that occur during the healing process at the tissue-level prompt the 
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measurement of stiffness and indentation modulus at additional time-points. Since the 
goal of this study was to provide an initial assessment of the ability of CECT to predict 
the stiffness of the callus, a single time-point was investigated. Throughout the healing 
process, the composition of the cartilage changes, as does relative contribution of 
cartilage to the stiffness of the callus. Therefore, it is possible that any relationships 
between CECT parameters and whole-callus or tissue-level stiffness are time-point-
specific. While this specificity may make it difficult to identify simple relationships 
between CECT parameters that would enable direct prediction of callus stiffness, CECT 
may still enable assessment of fracture healing that would lead to improved care. If 
CECT attenuation were translated to the clinic, the amount of cartilage could be used as a 
milestone to indicate progress towards healing. For example, a small amount of cartilage 
in the early stages may suggest a delay in healing that requires intervention. On the other 
hand, a large amount of cartilage, particularly later in the process, may suggest 
inadequate stability of the fracture.  
This was the first study to demonstrate axial compression of the murine fracture 
callus; however, there are several limitations with regards to these methods. First, it is 
possible that incubation in a cationic contrast agent would alter the fixed charge density 
and therefore alter the stiffness of the cartilage. Nonetheless, pilot studies demonstrated 
that the load curve was reproducible before incubation in contrast agent, after incubation 
in contrast agent for 8 hours, and after 24 hours of clearance in saline. Second, the 
compression of the callus is not perfectly axial. While every effort was made to prepare 
the callus such that it was aligned with the loading axis and excessively displaced 
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fractures were excluded from the study, neither the femur nor the callus is perfectly 
straight. Third, calluses at this time-point are extremely delicate, and six were excluded 
because they were damaged in the sample preparation leading up to mechanical testing 
(in addition to ten excluded due to highly displaced or comminuted fractures). Therefore, 
it is possible that the calluses tested in this study are biased toward more robust or stiff 
calluses. Fourth, it is possible that some of the displacement observed in the test was due 
to deformation of the PMMA used to embed the callus. While the system was calibrated 
to account for the average stiffness of PMMA, a method to more accurately measure 
displacement of the callus would be to create fiducial markers on the callus which could 
be tracked via camera. Unfortunately, the displacements in these tests are small (<0.2 
mm) and might be beyond the resolution of a camera.  
This is the first study to compare CECT attenuation with the tissue-level 
properties of the callus, yet there are limitations with regards to these methods. First, as 
with compression testing, it is possible that incubation in the contrast agent would alter 
the stiffness of the tissue. Because of the destructive nature of sample preparation for 
nanoindentation, it is not possible to test before and after indentation; however, the lack 
of effect on stiffness at the level of the whole callus suggests that there is no effect of the 
contrast agent on mechanical response. Second, because of the time-intensive nature of 
indentation tests, it was only possible to obtain up to five indents per sample. Thus, it was 
not possible to obtain a dense mapping of indentation modulus within each section. While 
pilot studies showed that the mean indentation modulus and standard error of the mean 
were stable with a minimum of five indents.  
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Third, the small number of indents, paired with the poor optics of the indenter, 
made it difficult to register the location indents to the corresponding location on 
histological and CECT sections. For this reason, indentation modulus, CECT attenuation, 
and red content were averaged over each section. However, examination of the CECT 
attenuation and red content of each section indicated a great deal of spatial variation 
within each section. Averaging over each section leads to a loss in the variation and limits 
the power to detect a relationship between CET attenuation or red content and indentation 
modulus. Perhaps by localizing each indent to the corresponding location in the 
histological section and matched CECT slice, it would be possible to capture the spatial 
variation. The coordinates of the callus boundary and indents were recorded and could be 
used to localize each indent to the histological sections and CECT slices. However, there 
are some limitations to this approach. First, the matching from the histological and 
nanoindentation sections to CECT slices is imperfect, particularly for samples with small 
amounts of cartilage. Second, the distribution of the red content from histological 
sections indicates that the safranin O staining is oversaturated, reducing the spatial 
variation.                
In summary, this study indicates that the stiffness of the fracture callus is 
negatively correlated to the size of the callus and the amount of cartilage in the callus but 
does not depend on the CECT attenuation of the cartilage. These results may reflect the 
formation of cartilage in response to low stability of the fracture site. In future work, 
these techniques may be applied to additional time points to determine how the stiffness 
of the callus and its relation to CECT parameters change throughout the healing process. 
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Additionally, the indentation modulus measured from nanoindentation can be paired with 
CECT scans to predict stiffness using sample-specific, voxel-based FE models. 
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CHAPTER FIVE : CONCLUSIONS AND FUTURE WORK 
CONCLUSIONS 
 The goal of this dissertation project was to apply CECT, a non-destructive, three-
dimensional imaging method, to understand the how the morphology and composition of 
cartilage changes in response to injury and disease.  CECT was applied to three models of 
injury or disease to answer specific, clinically relevant questions about the biological and 
mechanical behavior of cartilage. First, CECT was used to identify spatial changes to the 
growth plate cartilage in response to a pinhole injury. Next, the role of the A2BAR in the 
degradation of cartilage and bone in rheumatoid arthritis was quantified using CECT and 
a CAIA model. Finally, the use of CECT to develop predictions of the compressive 
stiffness of the fracture callus was assessed. Together, the results of this dissertation 
demonstrate that CECT is a powerful tool that may enable improved diagnostics and 
treatment of musculoskeletal injury and disease. 
 The three-dimensional nature of CECT allowed assessment of spatial changes to 
the growth plate that occur in response to injury. Growth plate thickness and CECT 
attenuation were increased near the injury site relative to far from the injury site and to 
the contralateral growth plate. Furthermore, both the volume and mineral density of bone 
formed at the injury site were higher than those of bone bridges formed outside the injury 
site and in the contralateral growth plate. These local changes to bone and cartilage 
measured by CECT were accompanied by increased hypertrophic zone height adjacent to 
the injury site and increased collagen X staining. These alterations in growth plate 
morphology, composition, and cellular activity indicate a local dysregulation of 
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endochondral ossification, which may contribute to disturbance in growth. These local 
changes in growth plate morphology and composition otherwise may not have been 
captured using histology or conventional µCT. The use of CECT would permit evaluation 
of therapies to prevent bone bridge formation that consider, not only formation of bone at 
the injury site, but also the health of the adjacent cartilage. 
 To ascertain the role of the A2BAR in rheumatoid arthritis, the degradation of 
bone and cartilage was evaluated using CECT. In both WT and KO mice, CAIA resulted 
in swelling of the paws, bone loss in the trabecular subchondral bone and subchondral 
bone of the tibia, and reduced CECT attenuation in the overlying cartilage of the tibia. 
However, there were no differences in the CAIA response between genotypes, indicating 
the A2BAR does not influence the degradation of bone and cartilage associated with 
CAIA. Thus, it is likely that other adenosine receptors provide an alternative pathway 
that mitigates degradation of bone and cartilage in the absence of the A2BAR, suggesting 
that therapies targeting adenosine receptors may require a combinational approach. The 
use of CECT enabled assessment of the role of a therapeutic target for RA by providing 
simultaneous three-dimensional quantification of the degradation of bone and cartilage. 
CECT can be used to evaluate drug candidates that mitigate bone and cartilage loss 
associated with RA and other disease that affect synovial joints. 
 To determine whether CECT can be used to predict the mechanical response of 
the fracture callus at early time points, the callus was tested in axial compression and the 
cartilage of the callus was tested using nanoindentation. While callus stiffness was 
negatively correlated to the size of the callus and amount of cartilage, there was no 
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relationship between stiffness and CECT attenuation either at the level of the whole 
callus compressive stiffness or at the level of cartilage indentation modulus. Because the 
tissue composition of the callus is heterogeneous, comprising cartilage, fibrous tissue, 
newly formed bone, and highly mineralized bone, it is likely that callus stiffness is 
controlled by a combination of both geometry and composition. Use of CECT may 
enable development specimen-specific, voxel-based FE models based on geometry and 
composition, consequently enabling non-invasive estimates of callus stiffness. 
 The CECT image processing methods developed during this dissertation work can 
be translated to study other cartilage pathologies. These methods were adapted from 
previous work on the callus, in which the intensity histogram of the subtracted histogram 
was fit by four Gaussian curves representing noise, PBS and non-cartilaginous soft tissue, 
cartilage, and bone.	(121) Depending on the tissues present and scanning conditions, the 
distributions may be different. For example, since it is possible for movement to occur at 
the fracture gap of the callus at early time-points, it is necessary to apply an upper 
threshold to exclude voxels that correspond to small regions of bone present in the 
subtracted image due to registration error. In contrast, with an intact long bone, as was 
the case for scans of the growth plate and articular cartilage, there is generally no 
distribution representing bone in the subtraction image. An additional consideration is 
whether to base measurements of cartilage on the subtraction or post-incubation image. 
In the case of the growth plate, CECT attenuation of the cartilage in the post-incubation 
image approached that of bone, necessitating use of the subtraction image. However, the 
thickness of the articular cartilage only exceeded the voxel size by a factor of ten, and 
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with the partial volume effect, the resolution limitations prevented use of the subtraction 
image. Since the CECT attenuation of the articular cartilage is lower than the growth 
plate, it was possible to distinguish between cartilage and bone. One approach developed 
for CECT of the growth plate and articular cartilage is the use of component labeling to 
identify contiguous voxels. Elimination of non-contiguous voxels reduced the false 
positive rate even at lower thresholds. Since the intensity distribution may vary 
depending on the pathology and site, when translating this method to other pathologies, it 
is important to adjust the image processing methods appropriately. 
 In addition to the image processing methods, the scan conditions, including 
incubation time may need to be optimized. Depending on the relative CECT attenuation 
of the cartilage in question and its dimensions relative to voxel size, it may be necessary 
to scan in humid air rather PBS. For example, scans of the growth plate and articular 
cartilage were performed in humid air to improve the contrast between background and 
cartilage. Additionally, the amount of time needed for the contrast agent to diffuse into 
the cartilage depends on the composition and geometry of the sample. The growth plate 
required particularly long incubations (14 hours compared to 8 hours for the callus). 
Diffusion of contrast agent into the growth plate may have been limited by the fact that 
only the periphery of the growth plate would initially be available to the solution. While 
it is important to achieve complete saturation of the cartilage, it is important not to 
incubation for so long that non-specific labeling of non-cartilaginous tissue, such as the 
bone marrow or fibrous tissue of the callus, begins to interfere with the ability to segment 
the cartilage. In addition, incubation time should be minimized to reduce the tissue 
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degradation. In order to identify the appropriate incubation time for a new type of sample, 
a time-course experiment should be undertaken. 
 While the work of this dissertation focused on growth plate injury, rheumatoid 
arthritis, and fracture healing, the approaches used and conclusions made are translatable 
to other pathologies involving the cartilage. Since CECT is a three-dimensional 
technique, it is particularly useful when studying irregularly shaped structures such as the 
growth plate and fracture callus, but CECT may also be used to monitor thinning of the 
articular cartilage associated with rheumatoid arthritis or osteoarthritis. Furthermore, it is 
possible to detect spatial variations in CECT attenuation, indicative of GAG content, that 
may be suggestive of the health of the cartilage or the underlying biological mechanism 
of disease. Identification heterogeneity in GAG content or local changes in GAG content 
may open up new research directions leading to novel therapies or diagnostic markers.  
  
FUTURE WORK 
 While the work presented in this dissertation demonstrates the value of CECT in 
characterizing the progression of injury and disease, this work also points toward new 
questions related to changes in bone and cartilage that may be answered with CECT. In 
parallel, there are additional questions regarding the underlying cellular and molecular 
mechanisms underlying the changes in bone and cartilage that cannot be answered by 
CECT but can be addressed using other approaches. 
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Growth Plate 
• What mechanisms are at work at the cellular and molecular level near the injury site? 
Both zonal measurements and immunostaining of collagen X indicate that there is 
increased hypertrophy near the injury site. Understanding the impact of injury on 
differentiation of chondrocytes near the injury site would shed light on the 
dysregulation of endochondral ossification that potentially leads to growth 
disturbance. Due to the processing associated with CECT, it was not possible to 
achieve successful staining of proliferative markers to verify observations of 
decreased proliferative zone height. In particular, it would be interesting to 
investigate local expression of factors that influence the transition from proliferative 
chondrocyte to hypertrophic chondrocyte, including parathyroid hormone receptor 
protein, bone morphogenetic proteins, vascular endothelial growth factor, and 
cytokines. 
• How would the local response be affected by interventions typically used for growth 
plate injury? CECT could be used to monitor and evaluate these interventions. While 
conventional µCT would show whether a bone bridge formed, CECT would also 
show whether the defect was eventually replaced by cartilage. Common interventions 
include surgically resecting the bone bridge, filling the defect site with material to 
prevent formation of bone bridges, and pharmacologically targeting factors that 
contribute to formation of bone bridges. 
• How does the size of the defect impact the local response of the growth plate cartilage 
and subsequent growth disturbance? In this study, the defect comprises only 5% of 
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the growth plate area and consequently resulted in only small growth disturbance. 
Interventions to prevent growth disturbances often unsuccessful when the injury 
affects more than 50% of the growth plate area. Perhaps one factor in these cases is 
that, as the injury size increases, a greater proportion of the uninjured growth plate is 
influenced by the local response near the injury site. 
Rheumatoid Arthritis 
• Are there any changes in the response of A2BAR KO and WT mice to CAIA at the 
level of bone remodeling or inflammatory response? There are no genotypic 
differences in the response to CAIA at the level of bone and cartilage, but it is 
possible that there are upstream differences that are somehow compensated for by 
other pathways. The levels of TNF-a in the serum will indicate any systemic changes 
in the inflammatory response, while mRNA expression and immunostaining will 
indicate local changes at the joints. TRAP staining, paired with mRNA expression of 
osteoblastic markers, will indicate any changes in bone remodeling. Since the 
literature indicates that the A2AAR may provide an alternate pathway to the A2BAR, it 
would be worthwhile to investigate any changes in mRNA expression or activity of 
the A2BAR. 
• How is the response to CAIA altered in the presence of various adenosine receptors 
or antagonists? With the role of the A2AAR suggested by the literature, it would be 
interesting to parse out the relative contributions of these adenosine receptors. While 
it would be impractical to apply a full panel of adenosine agonists and antagonists to 
an in vivo model, particularly a transgenic mouse model, in vitro experiments may 
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provide insight into the relative contributions of the various adenosine receptors. 
Adenosine agonists have been shown to reduce cytokine-induced collagenase in 
synoviocytes and increase osteoblastogenesis in osteoprogenitor cells. However, 
adenosine agonists have not been studied in the context of an in vitro model of 
inflammation in chondrocytes or bone cells, particularly osteoclasts.   
Fracture Healing 
• Would the whole-callus CECT-based predictions change across time points? As 
fracture healing progresses, the relative contributions of bone, cartilage, and fibrous 
tissue to the stiffness of the callus would change. For example, BV/TV and TMD are 
correlated with increased torsional stiffness at later time points. In contrast, at this 
early time point with no cortical bridging, BV/TV is not correlated with compressive 
stiffness, and TMD is negatively correlated with compressive stiffness. Furthermore, 
both the composition and organization of cartilage changes during fracture healing, 
and these changes may affect the contribution of cartilage to the stiffness of the 
callus. CECT scans and mechanical tests may need to be performed at multiple time 
points to identify time-point-specific relationships between CECT parameters and 
callus stiffness. 
• Would sample-specific, voxel-based FE models incorporating CECT data provide a 
useful estimate of fracture stiffness? Voxel-based FE models that distinguish between 
soft tissue, newly mineralized bone, and well-mineralized bone provide estimates of 
fracture stiffness in the later stages of fracture healing. Distinguishing between 
cartilage and other soft tissue of the callus may provide improved estimates at early 
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time points when bone does not contribute much to callus stiffness. Although the size 
of the callus and amount of cartilage in the callus were correlated to callus stiffness, it 
is likely that the arrangement of various callus tissues in space is influences the callus 
stiffness as well.  
CECT 
• Can CECT be developed for in vivo use? If so, CECT could enable longitudinal 
studies that evaluate the performance of experimental treatments in a multitude of 
injury and disease models. If translated to the clinic, CECT could enhance the ability 
of doctors to diagnose and monitor patients. In the case of growth plate injury, 
doctors could identify a defect in the growth plate cartilage in advance of formation 
of a bone bridge. In the case of rheumatoid arthritis, doctors could determine whether 
prescribed treatment is effectively protecting against bone and cartilage degradation. 
In the case of fracture healing, doctors could create patient-specific FE models that 
predict the stiffness of the fracture callus, allowing them to determine when a patient 
can return to weight-bearing. 	
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